Interleukin-4	B-protein
signaling	O
in	O
B	B-cell_type
lymphocytes	I-cell_type
from	O
patients	O
with	O
X-linked	O
severe	O
combined	O
immunodeficiency	O
.	O

Interleukin-4	B-protein
(	O
IL-4	B-protein
)	O
is	O
an	O
important	O
cytokine	O
for	O
B	O
and	O
T	O
lymphocyte	O
function	O
and	O
mediates	O
its	O
effects	O
via	O
a	O
receptor	O
that	O
contains	O
gammac	B-protein
.	O

B	B-cell_type
cells	I-cell_type
derived	O
from	O
patients	O
with	O
X-linked	O
severe	O
combined	O
immunodeficiency	O
(	O
X-SCID	O
)	O
are	O
deficient	O
in	O
gammac	O
and	O
provide	O
a	O
useful	O
model	O
in	O
which	O
to	O
dissect	O
the	O
role	O
of	O
this	O
subunit	O
in	O
IL-4	B-protein
-mediated	O
signaling	O
.	O

We	O
found	O
that	O
although	O
IL-4	B-protein
stimulation	O
of	O
X-SCID	B-cell_type
B	I-cell_type
cells	I-cell_type
did	O
not	O
result	O
in	O
Janus	B-protein
tyrosine	I-protein
kinase-3	I-protein
(	O
JAK3	B-protein
)	O
phosphorylation	O
,	O
other	O
IL-4	B-protein
substrates	I-protein
including	O
JAK1	B-protein
and	O
IRS-1	B-protein
were	O
phosphorylated	O
.	O

Additionally	O
,	O
we	O
detected	O
signal	B-protein
transducers	I-protein
and	I-protein
activators	I-protein
of	I-protein
transcription	I-protein
6	I-protein
(	O
STAT6	B-protein
)	O
tyrosine	O
phosphorylation	O
and	O
DNA	O
binding	O
activity	O
in	O
X-SCID	B-cell_type
B	I-cell_type
cells	I-cell_type
with	O
a	O
wide	O
range	O
of	O
gammac	B-protein
mutations	O
.	O

However	O
,	O
reconstitution	O
of	O
these	O
X-SCID	B-cell_type
B	I-cell_type
cells	I-cell_type
with	O
gammac	B-protein
enhanced	O
IL-4	B-protein
-mediated	O
responses	O
including	O
STAT6	B-protein
phosphorylation	O
and	O
DNA	O
binding	O
activity	O
and	O
resulted	O
in	O
increased	O
CD23	B-protein
expression	O
.	O

Thus	O
,	O
gammac	B-protein
is	O
not	O
necessary	O
to	O
trigger	O
IL-4	B-protein
-mediated	O
responses	O
in	O
B	B-cell_type
cells	I-cell_type
,	O
but	O
its	O
presence	O
is	O
important	O
for	O
optimal	O
IL-4	B-protein
-signaling	O
.	O

These	O
results	O
suggest	O
that	O
two	O
distinct	O
IL-4	B-protein
signaling	O
pathways	O
exist	O
.	O

THE	NULL
JOURNAL	NULL
or	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
Vol	NULL
.	NULL

272	NULL
,	NULL
No	NULL
.	NULL

11	NULL
,	NULL
Issue	NULL
of	NULL
March	NULL
14	NULL
,	NULL
pp	NULL
.	NULL

7314-7319	NULL
,	NULL
1997	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
Interleukin-4	NULL
Signaling	NULL
in	NULL
B	NULL
Lymphocytes	NULL
from	NULL
Patients	NULL
with	NULL
X-linked	NULL
Severe	NULL
Combined	NULL
Immunodeficiency*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
October	NULL
29	NULL
,	NULL
1996	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
December	NULL
17	NULL
,	NULL
1996	NULL
)	NULL
Naomi	NULL
Fabio	NULL
Candotti|**	NULL
,	NULL
Susan	NULL
Smitht	NULL
$	NULL
,	NULL
Scott	NULL
A.	NULL
Oakes	NULL
#	NULL
$	NULL
,	NULL
Thomas	NULL
Jahnt	NULL
,	NULL
Judith	NULL
Isakov	NULL
$	NULL
§	NULL
$	NULL
§	NULL
,	NULL
Jennifer	NULL
M.	NULL
Puck	NULL
{	NULL
§§	NULL
,	NULL
John	NULL
J.	NULL
O'Sheaf	NULL
$	NULL
,	NULL
Kenneth	NULL
Weinbergt	NULL
,	NULL
and	NULL
James	NULL
A.	NULL
Johnstont	NULL
}	NULL
11	NULL
From	NULL
the	NULL
{	NULL
Division	NULL
of	NULL
Research	NULL
Immunology	NULL
and	NULL
Bone	NULL
Marrow	NULL
Transplantation	NULL
,	NULL
Childrens	NULL
Hospital	NULL
Los	NULL
Angeles	NULL
,	NULL
Los	NULL
Angeles	NULL
,	NULL
California	NULL
90027	NULL
,	NULL
§Institut	NULL
de	NULL
Génétique	NULL
Moléculaire	NULL
de	NULL
Montpellier	NULL
,	NULL
34033	NULL
Montpellier	NULL
,	NULL
France	NULL
,	NULL
Clinical	NULL
Gene	NULL
Therapy	NULL
Branch	NULL
,	NULL
National	NULL
Center	NULL
for	NULL
Human	NULL
Genome	NULL
Research	NULL
,	NULL
t	NULL
{	NULL
Lymphocyte	NULL
Cell	NULL
Biology	NULL
Section	NULL
,	NULL
NIAMSD	NULL
and	NULL
§§Immunological	NULL
Genetics	NULL
Section	NULL
,	NULL
National	NULL
Center	NULL
for	NULL
Human	NULL
Genome	NULL
Research	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Bethesda	NULL
,	NULL
Maryland	NULL
20855	NULL
Interleukin-4	NULL
(	NULL
IL-4	NULL
)	NULL
is	NULL
an	NULL
important	NULL
cytokine	NULL
for	NULL
B	NULL
and	NULL
T	NULL
lymphocyte	NULL
function	NULL
and	NULL
mediates	NULL
its	NULL
effects	NULL
via	NULL
a	NULL
receptor	NULL
that	NULL
contains	NULL
y	NULL
,	NULL
.	NULL

B	NULL
cells	NULL
derived	NULL
from	NULL
patients	NULL
with	NULL
X-linked	NULL
severe	NULL
combined	NULL
immunodeficiency	NULL
(	NULL
X-SCID	NULL
)	NULL
are	NULL
deficient	NULL
in	NULL
y	NULL
,	NULL
and	NULL
provide	NULL
a	NULL
useful	NULL
model	NULL
in	NULL
which	NULL
to	NULL
dissect	NULL
the	NULL
role	NULL
of	NULL
this	NULL
subunit	NULL
in	NULL
IL-4-mediated	NULL
signaling	NULL
.	NULL

We	NULL
found	NULL
that	NULL
although	NULL
IL-4	NULL
stimulation	NULL
of	NULL
X-SCID	NULL
B	NULL
cells	NULL
did	NULL
not	NULL
result	NULL
in	NULL
Janus	NULL
tyrosine	NULL
kinase-3	NULL
(	NULL
JAK3	NULL
)	NULL
phosphorylation	NULL
,	NULL
other	NULL
IL-4	NULL
substrates	NULL
including	NULL
JAK1	NULL
and	NULL
IRS-1	NULL
were	NULL
phosphorylated	NULL
.	NULL

Additionally	NULL
,	NULL
we	NULL
detected	NULL
signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcription	NULL
6	NULL
(	NULL
STAT6	NULL
)	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
X-SCID	NULL
B	NULL
cells	NULL
with	NULL
a	NULL
wide	NULL
range	NULL
of	NULL
y	NULL
,	NULL
mutations	NULL
.	NULL

However	NULL
,	NULL
reconstitution	NULL
of	NULL
these	NULL
X-SCID	NULL
B	NULL
cells	NULL
with	NULL
y	NULL
,	NULL
,	NULL
enhanced	NULL
IL-4-mediated	NULL
responses	NULL
including	NULL
STAT6G	NULL
phosphorylation	NULL
and	NULL
DNA	NULL
binding	NULL
activity	NULL
and	NULL
resulted	NULL
in	NULL
increased	NULL
CD23	NULL
expression	NULL
.	NULL

Thus	NULL
,	NULL
y	NULL
,	NULL
is	NULL
not	NULL
necessary	NULL
to	NULL
trigger	NULL
IL-4-mediated	NULL
responses	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
but	NULL
its	NULL
presence	NULL
is	NULL
important	NULL
for	NULL
optimal	NULL
IL-4-sig-naling	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
two	NULL
distinct	NULL
IL-4	NULL
signaling	NULL
pathways	NULL
exist	NULL
.	NULL

Patients	NULL
with	NULL
X-linked	NULL
severe	NULL
combined	NULL
immunodeficiency	NULL
(	NULL
X-SCID	NULL
)	NULL
'	NULL
present	NULL
with	NULL
very	NULL
few	NULL
T	NULL
cells	NULL
and	NULL
absent	NULL
mitogenic	NULL
responses	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Although	NULL
B	NULL
cells	NULL
are	NULL
present	NULL
,	NULL
immunoglobulin	NULL
levels	NULL
are	NULL
low	NULL
,	NULL
and	NULL
specific	NULL
antibody	NULL
production	NULL
is	NULL
lacking	NULL
.	NULL

The	NULL
combination	NULL
of	NULL
these	NULL
defects	NULL
is	NULL
fatal	NULL
by	NULL
1-2	NULL
years	NULL
of	NULL
age	NULL
unless	NULL
the	NULL
immune	NULL
system	NULL
is	NULL
reconstituted	NULL
by	NULL
allogeneic	NULL
bone	NULL
marrow	NULL
transplantation	NULL
.	NULL

These	NULL
clinical	NULL
manifestations	NULL
are	NULL
due	NULL
to	NULL
a	NULL
*This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
a	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
Postdoctoral	NULL
Physician	NULL
Grant	NULL
(	NULL
to	NULL
N.	NULL
T.	NULL
)	NULL
,	NULL
the	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute-National	NULL
Institutes	NULL
of	NULL
Health	NULL
Research	NULL
Scholars	NULL
Program	NULL
(	NULL
to	NULL
S.	NULL
A	NULL
.	NULL

O	NULL
.	NULL
)	NULL

,	NULL
the	NULL
Fondation	NULL
pour	NULL
la	NULL
Recherche	NULL
Medicale	NULL
,	NULL
Philippe	NULL
Foundation	NULL
,	NULL
and	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grant	NULL
AI25071	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
adver-fisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

1	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Institut	NULL
de	NULL
Génétique	NULL
Moléculaire	NULL
de	NULL
Montpellier	NULL
,	NULL
1919	NULL
Route	NULL
de	NULL
Mende	NULL
,	NULL
34083	NULL
Montpellier	NULL
,	NULL
Cedex	NULL
1	NULL
France	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
88-467	NULL
61	NULL
36	NULL
28	NULL
;	NULL
Fax	NULL
:	NULL
33-467	NULL
04	NULL
02	NULL
31	NULL
;	NULL
E-mail	NULL
:	NULL
taylor	NULL
@	NULL
igm.cnrs-mop.fr	NULL
.	NULL

**	NULL
Present	NULL
address	NULL
:	NULL
Dept	NULL
.	NULL

of	NULL
Pediatrics	NULL
,	NULL
University	NULL
of	NULL
Brescia	NULL
,	NULL
Spedali	NULL
Civili	NULL
,	NULL
251283	NULL
Brescia	NULL
,	NULL
Italy	NULL
.	NULL

T	NULL
Present	NULL
address	NULL
:	NULL
DNAX	NULL
Research	NULL
Institute	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
94804	NULL
.	NULL

*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
X-SCID	NULL
,	NULL
X-linked	NULL
severe	NULL
combined	NULL
im-munodeficiency	NULL
;	NULL
IL	NULL
,	NULL
interleukin	NULL
;	NULL
JAK	NULL
,	NULL
Janus	NULL
tyrosine	NULL
kinase	NULL
;	NULL
STAT	NULL
,	NULL
signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcription	NULL
;	NULL
B-LCL	NULL
,	NULL
B	NULL
cell	NULL
lym-phoblastoid	NULL
cell	NULL
lines	NULL
;	NULL
GAS	NULL
,	NULL
interferon-y	NULL
activation	NULL
site	NULL
;	NULL
R	NULL
,	NULL
receptor	NULL
;	NULL
IRS	NULL
,	NULL
insulin	NULL
receptor	NULL
substrate	NULL
.	NULL

78314	NULL
wide	NULL
range	NULL
of	NULL
mutations	NULL
in	NULL
the	NULL
common	NULL
gamma	NULL
chain	NULL
(	NULL
y	NULL
,	NULL
)	NULL
gene	NULL
that	NULL
result	NULL
in	NULL
either	NULL
a	NULL
lack	NULL
of	NULL
y	NULL
,	NULL
message	NULL
,	NULL
unstable	NULL
y	NULL
,	NULL
proteins	NULL
that	NULL
are	NULL
poorly	NULL
expressed	NULL
,	NULL
or	NULL
defective	NULL
y	NULL
,	NULL
receptor	NULL
subunits	NULL
that	NULL
are	NULL
expressed	NULL
but	NULL
nonfunctional	NULL
(	NULL
2-4	NULL
)	NULL
.	NULL

y	NULL
,	NULL
was	NULL
originally	NULL
identified	NULL
as	NULL
a	NULL
component	NULL
of	NULL
the	NULL
IL-2	NULL
cytokine	NULL
receptor	NULL
(	NULL
IL-2Ry	NULL
)	NULL
,	NULL
but	NULL
as	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
shared	NULL
by	NULL
receptors	NULL
for	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
IL-7	NULL
,	NULL
IL-9	NULL
,	NULL
and	NULL
IL-15	NULL
,	NULL
it	NULL
is	NULL
now	NULL
designated	NULL
y	NULL
,	NULL
,	NULL
(	NULL
5-9	NULL
)	NULL
.	NULL

IL-4	NULL
is	NULL
thought	NULL
to	NULL
be	NULL
important	NULL
for	NULL
mature	NULL
B	NULL
cell	NULL
functions	NULL
including	NULL
immunoglobulin	NULL
class	NULL
switching	NULL
to	NULL
IgG4	NULL
and	NULL
IgE	NULL
as	NULL
well	NULL
as	NULL
expression	NULL
of	NULL
CD23	NULL
and	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II	NULL
genes	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Because	NULL
IL-4	NULL
regulates	NULL
B	NULL
lymphocyte	NULL
function	NULL
,	NULL
it	NULL
is	NULL
important	NULL
to	NULL
determine	NULL
the	NULL
response	NULL
of	NULL
X-SCID	NULL
B	NULL
cells	NULL
to	NULL
this	NULL
cytokine	NULL
.	NULL

The	NULL
functional	NULL
IL-4	NULL
receptor	NULL
(	NULL
IL-4R	NULL
)	NULL
consists	NULL
of	NULL
at	NULL
least	NULL
two	NULL
components	NULL
,	NULL
IL-4Ra	NULL
and	NULL
y	NULL
,	NULL
,	NULL
subunits	NULL
(	NULL
6	NULL
,	NULL
11	NULL
)	NULL
.	NULL

Signal	NULL
transduction	NULL
through	NULL
the	NULL
IL-4R	NULL
,	NULL
as	NULL
well	NULL
as	NULL
through	NULL
other	NULL
hematopoietic	NULL
receptors	NULL
,	NULL
is	NULL
initiated	NULL
by	NULL
activation	NULL
of	NULL
Janus	NULL
family	NULL
tyrosine	NULL
kinases	NULL
(	NULL
JAKs	NULL
)	NULL
(	NULL
12	NULL
,	NULL
13	NULL
)	NULL
.	NULL

IL-4	NULL
elicits	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
the	NULL
JAK	NULL
family	NULL
members	NULL
JAK1	NULL
and	NULL
JAK3	NULL
,	NULL
which	NULL
interact	NULL
with	NULL
the	NULL
IL-4Ra	NULL
and	NULL
y	NULL
,	NULL
subunits	NULL
,	NULL
respectively	NULL
(	NULL
14-17	NULL
)	NULL
.	NULL

The	NULL
current	NULL
model	NULL
of	NULL
cytokine	NULL
signaling	NULL
proposes	NULL
that	NULL
upon	NULL
cytokine	NULL
binding	NULL
,	NULL
members	NULL
of	NULL
the	NULL
JAK	NULL
family	NULL
are	NULL
rapidly	NULL
activated	NULL
and	NULL
subsequently	NULL
tyrosine-phosphorylate	NULL
the	NULL
receptor	NULL
,	NULL
forming	NULL
a	NULL
docking	NULL
site	NULL
for	NULL
signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcription	NULL
(	NULL
STATs	NULL
)	NULL
that	NULL
are	NULL
also	NULL
phosphorylated	NULL
by	NULL
JAKs	NULL
(	NULL
12	NULL
,	NULL
13	NULL
)	NULL
.	NULL

The	NULL
STAT	NULL
proteins	NULL
then	NULL
dimerize	NULL
and	NULL
translocate	NULL
to	NULL
the	NULL
nucleus	NULL
where	NULL
they	NULL
bind	NULL
DNA	NULL
sequences	NULL
on	NULL
target	NULL
genes	NULL
.	NULL

One	NULL
important	NULL
STAT	NULL
that	NULL
is	NULL
activated	NULL
in	NULL
response	NULL
to	NULL
IL-4	NULL
,	NULL
STAT6	NULL
(	NULL
IL-4	NULL
STAT	NULL
)	NULL
,	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
to	NULL
promoter	NULL
sequences	NULL
of	NULL
IL-4-inducible	NULL
genes	NULL
(	NULL
18-21	NULL
)	NULL
.	NULL

As	NULL
STAT6	NULL
knockout	NULL
animals	NULL
parallel	NULL
the	NULL
IL-4	NULL
null	NULL
phenotype	NULL
and	NULL
exhibit	NULL
defects	NULL
in	NULL
Th2	NULL
helper	NULL
T	NULL
cell	NULL
differentiation	NULL
and	NULL
immunoglobulin	NULL
class	NULL
switching	NULL
(	NULL
22-24	NULL
)	NULL
,	NULL
STAT6	NULL
appears	NULL
to	NULL
be	NULL
essential	NULL
for	NULL
many	NULL
IL-4-mediated	NULL
effects	NULL
.	NULL

It	NULL
might	NULL
be	NULL
predicted	NULL
that	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
a	NULL
functional	NULL
y	NULL
,	NULL
chain	NULL
,	NULL
X-SCID	NULL
B	NULL
cells	NULL
would	NULL
not	NULL
be	NULL
able	NULL
to	NULL
respond	NULL
to	NULL
IL-4	NULL
.	NULL

Indeed	NULL
,	NULL
two	NULL
groups	NULL
have	NULL
reported	NULL
that	NULL
neither	NULL
JAK1	NULL
phosphorylation	NULL
nor	NULL
STAT6	NULL
DNA	NULL
binding	NULL
activity	NULL
is	NULL
induced	NULL
upon	NULL
IL-4	NULL
stimulation	NULL
of	NULL
Epstein-Barr	NULL
virus-transformed	NULL
B	NULL
cells	NULL
(	NULL
B-LCL	NULL
)	NULL
derived	NULL
from	NULL
X-SCID	NULL
patients	NULL
(	NULL
25	NULL
,	NULL
26	NULL
)	NULL
.	NULL

However	NULL
,	NULL
Matthews	NULL
and	NULL
colleagues	NULL
(	NULL
27	NULL
)	NULL
have	NULL
recently	NULL
demonstrated	NULL
that	NULL
although	NULL
X-SCID	NULL
B	NULL
cells	NULL
can	NULL
not	NULL
undergo	NULL
immunoglobulin	NULL
class	NULL
switching	NULL
,	NULL
they	NULL
can	NULL
proliferate	NULL
in	NULL
vitro	NULL
in	NULL
response	NULL
to	NULL
IL-4	NULL
when	NULL
co-stimulated	NULL
with	NULL
CD40	NULL
ligand	NULL
or	NULL
anti-IgM	NULL
.	NULL

Although	NULL
the	NULL
underlying	NULL
biochemical	NULL
mechanisms	NULL
are	NULL
not	NULL
clear	NULL
,	NULL
these	NULL
data	NULL
suggest	NULL
that	NULL
IL-4-mediated	NULL
signaling	NULL
in	NULL
X-SCID	NULL
B	NULL
cells	NULL
can	NULL
occur	NULL
.	NULL

It	NULL
was	NULL
therefore	NULL
important	NULL
to	NULL
analyze	NULL
IL-4-signaling	NULL
in	NULL
a	NULL
panel	NULL
of	NULL
B-LCL	NULL
derived	NULL
from	NULL
X-SCID	NULL
patients	NULL
with	NULL
a	NULL
wide	NULL
range	NULL
of	NULL
y	NULL
,	NULL
mutations	NULL
in	NULL
order	NULL
to	NULL
clarify	NULL
these	NULL
discrepancies	NULL
.	NULL

This	NULL
paper	NULL
is	NULL
available	NULL
on	NULL
line	NULL
at	NULL
http	NULL
:	NULL
//www-jbc.stanford.edu/jbc/	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
IL-4	NULL
Signaling	NULL
in	NULL
X-SCID	NULL
B	NULL
Cells	NULL
IL-4	NULL
failed	NULL
to	NULL
stimulate	NULL
JAK3	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
X-SCID	NULL
B	NULL
cells	NULL
,	NULL
but	NULL
we	NULL
found	NULL
that	NULL
JAK1	NULL
and	NULL
IRS-1	NULL
were	NULL
phosphorylated	NULL
.	NULL

IL-4	NULL
also	NULL
induced	NULL
STAT6	NULL
phosphorylation	NULL
as	NULL
well	NULL
as	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
STAT6	NULL
activation	NULL
and	NULL
CD23	NULL
expression	NULL
were	NULL
significantly	NULL
enhanced	NULL
in	NULL
X-SCID	NULL
B-LCL	NULL
reconstituted	NULL
with	NULL
wild	NULL
type	NULL
y	NULL
,	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
have	NULL
demonstrated	NULL
a	NULL
7.	NULL
,	NULL
-JAK83-independent	NULL
pathway	NULL
through	NULL
which	NULL
IL-4	NULL
activates	NULL
JAK1	NULL
and	NULL
STAT6	NULL
in	NULL
B	NULL
cells	NULL
derived	NULL
from	NULL
X-SCID	NULL
patients	NULL
.	NULL

These	NULL
results	NULL
have	NULL
important	NULL
implications	NULL
for	NULL
the	NULL
understanding	NULL
of	NULL
IL-4	NULL
signal	NULL
transduction	NULL
and	NULL
the	NULL
lack	NULL
of	NULL
mature	NULL
B	NULL
cell	NULL
function	NULL
in	NULL
patients	NULL
with	NULL
X-SCID	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Cytokines	NULL
and	NULL
Antibodies-Recombinant	NULL
human	NULL
IL-2	NULL
and	NULL
IL-18	NULL
were	NULL
the	NULL
generous	NULL
gifts	NULL
of	NULL
C.	NULL
Paradise	NULL
(	NULL
Chiron	NULL
Corp.	NULL
,	NULL
Emeryville	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
C.	NULL
Reynolds	NULL
(	NULL
BRMP	NULL
,	NULL
Frederick	NULL
,	NULL
MD	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

Polyclonal	NULL
rabbit	NULL
antisera	NULL
against	NULL
STAT6G	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
R.	NULL
LaRochelle	NULL
(	NULL
National	NULL
Cancer	NULL
Institute	NULL
,	NULL
Bethesda	NULL
)	NULL
or	NULL
was	NULL
obtained	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
Inc.	NULL
(	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Anti-JAK1	NULL
antibodies	NULL
were	NULL
purchased	NULL
from	NULL
Transduction	NULL
Laboratories	NULL
(	NULL
Lexington	NULL
,	NULL
KY	NULL
)	NULL
and	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
Inc.	NULL
Anti-IRS-1	NULL
antibodies	NULL
were	NULL
obtained	NULL
from	NULL
J	NULL
.	NULL

Pierce	NULL
(	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Bethesda	NULL
)	NULL
.	NULL

The	NULL
4G10	NULL
monoclonal	NULL
anti-phosphotyrosine	NULL
antibody	NULL
was	NULL
purchased	NULL
from	NULL
Upstate	NULL
Biotechnology	NULL
Inc.	NULL
(	NULL
Lake	NULL
Placid	NULL
,	NULL
NY	NULL
)	NULL
,	NULL
and	NULL
the	NULL
pY72	NULL
anti-phosphotyrosine	NULL
was	NULL
the	NULL
gift	NULL
of	NULL
B.	NULL
Sefton	NULL
(	NULL
Salk	NULL
Institute	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Cell	NULL
Lines-Male	NULL
patients	NULL
with	NULL
SCID	NULL
were	NULL
initially	NULL
diagnosed	NULL
with	NULL
the	NULL
X-linked	NULL
form	NULL
based	NULL
on	NULL
maternal	NULL
X	NULL
chromosome	NULL
inactivation	NULL
patterns	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
from	NULL
X-SCID	NULL
patients	NULL
and	NULL
normal	NULL
donors	NULL
were	NULL
obtained	NULL
upon	NULL
informed	NULL
consent	NULL
,	NULL
and	NULL
B	NULL
cell	NULL
lym-phoblastoid	NULL
cell	NULL
lines	NULL
(	NULL
B-LCL	NULL
)	NULL
were	NULL
established	NULL
by	NULL
Epstein-Barr	NULL
virus	NULL
immortalization	NULL
.	NULL

The	NULL
mutations	NULL
in	NULL
the	NULL
y	NULL
,	NULL
gene	NULL
in	NULL
each	NULL
X-SCID	NULL
B-LCL	NULL
have	NULL
been	NULL
previously	NULL
described	NULL
(	NULL
8	NULL
,	NULL
28	NULL
,	NULL
29	NULL
)	NULL
.	NULL

Each	NULL
X-SCID	NULL
B-LCL	NULL
is	NULL
named	NULL
by	NULL
the	NULL
position	NULL
and	NULL
identity	NULL
of	NULL
the	NULL
base	NULL
pair	NULL
or	NULL
amino	NULL
acid	NULL
substitution	NULL
within	NULL
the	NULL
y	NULL
,	NULL
cDNA	NULL
or	NULL
protein	NULL
,	NULL
respectively	NULL
.	NULL

M1I	NULL
has	NULL
an	NULL
M	NULL
to	NULL
I	NULL
substitution	NULL
at	NULL
amino	NULL
acid	NULL
1	NULL
,	NULL
and	NULL
other	NULL
substitutions	NULL
include	NULL
R224W	NULL
,	NULL
R226C	NULL
,	NULL
R226H	NULL
,	NULL
and	NULL
F227C	NULL
.	NULL

R289*	NULL
prematurely	NULL
terminates	NULL
the	NULL
y	NULL
,	NULL
protein	NULL
at	NULL
R289	NULL
,	NULL
dup235-7	NULL
has	NULL
a	NULL
duplication	NULL
of	NULL
amino	NULL
acids	NULL
235-237	NULL
,	NULL
924delC	NULL
has	NULL
a	NULL
C	NULL
deleted	NULL
at	NULL
cDNA	NULL
position	NULL
924	NULL
resulting	NULL
in	NULL
a	NULL
missense	NULL
amino	NULL
acid	NULL
after	NULL
amino	NULL
acid	NULL
308	NULL
.	NULL

The	NULL
X-SCID	NULL
B-LCL	NULL
identified	NULL
as	NULL
cDNA468+1	NULL
has	NULL
a	NULL
mutation	NULL
which	NULL
disrupts	NULL
the	NULL
splice	NULL
donor	NULL
site	NULL
after	NULL
exon	NULL
3	NULL
and	NULL
results	NULL
in	NULL
no	NULL
detectable	NULL
y	NULL
,	NULL
mRNA	NULL
(	NULL
8	NULL
)	NULL
.	NULL

The	NULL
X-SCID	NULL
B-LCL	NULL
cDNA468+1	NULL
(	NULL
boy	NULL
5	NULL
)	NULL
into	NULL
which	NULL
the	NULL
wild	NULL
type	NULL
y	NULL
,	NULL
,	NULL
gene	NULL
was	NULL
introduced	NULL
by	NULL
retroviral	NULL
mediated	NULL
transduction	NULL
has	NULL
previously	NULL
been	NULL
reported	NULL
(	NULL
80	NULL
)	NULL
and	NULL
is	NULL
noted	NULL
as	NULL
cDNA468+1/y	NULL
,	NULL
.	NULL

Expression	NULL
of	NULL
y	NULL
,	NULL
protein	NULL
on	NULL
the	NULL
cell	NULL
surface	NULL
of	NULL
control	NULL
and	NULL
X-SCID	NULL
B-LCL	NULL
was	NULL
assessed	NULL
using	NULL
a	NULL
y.-specific	NULL
rat	NULL
monoclonal	NULL
antibody	NULL
,	NULL
TUGH4	NULL
(	NULL
Pharmigen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Immunoflu-oresence	NULL
analyses	NULL
revealed	NULL
either	NULL
normal	NULL
,	NULL
trace	NULL
,	NULL
or	NULL
absent	NULL
levels	NULL
of	NULL
y	NULL
,	NULL
protein	NULL
on	NULL
the	NULL
cell	NULL
surface	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
HUT78	NULL
T	NULL
cell	NULL
line	NULL
was	NULL
obtained	NULL
from	NULL
the	NULL
ATCC	NULL
(	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

All	NULL
cell	NULL
lines	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
2	NULL
mM	NULL
glutamine	NULL
,	NULL
50	NULL
units/ml	NULL
penicillin	NULL
,	NULL
and	NULL
50	NULL
ug/ml	NULL
streptomycin	NULL
.	NULL

Immunoprecipitation	NULL
and	NULL
Western	NULL
Blotting	NULL
Analysis-Cells	NULL
were	NULL
stimulated	NULL
essentially	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
cells	NULL
were	NULL
resuspended	NULL
at	NULL
1	NULL
X	NULL
10	NULL
``	NULL
cells/ml	NULL
and	NULL
incubated	NULL
with	NULL
either	NULL
10°	NULL
units/ml	NULL
IL-2	NULL
,	NULL
100	NULL
ng/ml	NULL
IL-4	NULL
,	NULL
or	NULL
250	NULL
ng/ml	NULL
IL-18	NULL
.	NULL

After	NULL
10	NULL
min	NULL
,	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
a	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
lysis	NULL
buffer	NULL
.	NULL

Supernatants	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
the	NULL
specified	NULL
antibody	NULL
at	NULL
4	NULL
°C	NULL
,	NULL
and	NULL
immunoprecipitates	NULL
were	NULL
collected	NULL
on	NULL
protein	NULL
A/G	NULL
agarose	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
Inc.	NULL
)	NULL
and	NULL
separated	NULL
on	NULL
7.5	NULL
%	NULL
SDS-polyacrylamide	NULL
gels	NULL
.	NULL

Membranes	NULL
were	NULL
blotted	NULL
with	NULL
the	NULL
4G10	NULL
and	NULL
pY72	NULL
anti-phosphotyrosine	NULL
mABs	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Blots	NULL
probed	NULL
with	NULL
polyclonal	NULL
JAK1	NULL
,	NULL
JAK3	NULL
,	NULL
STAT6	NULL
,	NULL
and	NULL
IRS-1	NULL
antibodies	NULL
were	NULL
blocked	NULL
in	NULL
TBS	NULL
(	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
20	NULL
mM	NULL
Tris	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
)	NULL
containing	NULL
5	NULL
%	NULL
bovine	NULL
serum	NULL
albumin	NULL
and	NULL
0.1	NULL
%	NULL
Tween	NULL
20	NULL
.	NULL

Blots	NULL
were	NULL
incubated	NULL
sequentially	NULL
with	NULL
the	NULL
primary	NULL
antibody	NULL
and	NULL
horseradish	NULL
peroxidase-conjugated	NULL
goat	NULL
anti-rabbit	NULL
IgG	NULL
(	NULL
Amersham	NULL
Corp.	NULL
)	NULL
and	NULL
visualized	NULL
using	NULL
the	NULL
enhanced	NULL
chemiluminescence	NULL
detection	NULL
system	NULL
(	NULL
Amersham	NULL
Corp.	NULL
)	NULL
.	NULL

For	NULL
reblotting	NULL
,	NULL
filters	NULL
were	NULL
stripped	NULL
as	NULL
reported	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assay-B-LCLs	NULL
were	NULL
cultured	NULL
without	NULL
serum	NULL
for	NULL
4	NULL
h	NULL
prior	NULL
to	NULL
a	NULL
15-min	NULL
stimulation	NULL
with	NULL
IL-4	NULL
or	NULL
IL-13	NULL
(	NULL
1000	NULL
units/ml	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
lysed	NULL
in	NULL
a	NULL
buffer	NULL
containing	NULL
0.5	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
50	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
8.0	NULL
)	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
100	NULL
mM	NULL
EDTA	NULL
(	NULL
pH	NULL
8.0	NULL
)	NULL
,	NULL
50	NULL
mM	NULL
NaF	NULL
,	NULL
150	NULL
mm	NULL
NaCl	NULL
,	NULL
100	NULL
mM	NULL
Na	NULL
,	NULL
;	NULL
VO	NULL
,	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
400	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
and	NULL
1	NULL
mg/ml	NULL
leupeptin	NULL
and	NULL
aprotinin	NULL
.	NULL

Whole	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
centrifugation	NULL
,	NULL
and	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
were	NULL
performed	NULL
essentially	NULL
as	NULL
reported	NULL
(	NULL
82	NULL
)	NULL
,	NULL
using	NULL
a	NULL
°°P	NULL
random	NULL
prime-labeled	NULL
double-stranded	NULL
oligonucleo-	NULL
78315	NULL
Jak3	NULL
IP	NULL
YclF	NULL
4+	NULL
w	NULL
==	NULL
w=	NULL
Tr	NULL
Tr	NULL
+	NULL
4+	NULL
4	NULL
T	NULL
i	NULL
z	NULL
o	NULL
-	NULL
bo*s	NULL
-	NULL
o	NULL
B	NULL
$	NULL
-	NULL
&	NULL
§	NULL
E	NULL
-	NULL
$	NULL
®	NULL
rn	NULL
2	NULL
3	NULL
ou	NULL
o	NULL
cu	NULL
xd	NULL
Cu	NULL
i	NULL
a	NULL
<	NULL
o	NULL
ou	NULL
£	NULL
CC	NULL
3	NULL
o	NULL
CC	NULL
CC	NULL
LL	NULL
hel	NULL
L	NULL
(	NULL
mdvam	NULL
Amtrinlandrami	NULL
ante	NULL
Stu	NULL
NT	NULL
<	NULL
n	NULL
ais	NULL
ds	NULL
as	NULL
ta	NULL
ste	NULL
aes	NULL
3m	NULL
the	NULL
cee	NULL
wn	NULL
outh	NULL
Anti-P-Tyr	NULL
euutunass	NULL
oo	NULL
san	NULL
tut	NULL
GB	NULL
ous	NULL
ont	NULL
to	NULL
wo	NULL
wo	NULL
on	NULL
as	NULL
aas	NULL
-	NULL
.	NULL

cmc	NULL
On	NULL
Ann	NULL
~~	NULL
Gib	NULL
oan	NULL
aap	NULL
man	NULL
men	NULL
-+	NULL
Anti-Jak3	NULL
B	NULL
Jak	NULL
1	NULL
IP	NULL
YoIF	NULL
<	NULL
P	NULL
w	NULL
wam	NULL
Tr	NULL
4	NULL
+	NULL
Control	NULL
_	NULL
R224W	NULL
-	NULL
R226C	NULL
_	NULL
dup235-7	NULL
-	NULL
_Rz2s9	NULL
``	NULL
6	NULL
yo	NULL
a	NULL
tt	NULL
a	NULL
t	NULL
yu	NULL
C	NULL
tol	NULL
v	NULL
vg	NULL
ov	NULL
r	NULL
=	NULL
.	NULL

a	NULL
=	NULL
=	NULL
=	NULL
:	NULL
4	NULL
``	NULL
)	NULL
&	NULL
a	NULL
L	NULL
40	NULL
L	NULL
wee	NULL
«	NULL
-	NULL
te	NULL
ames	NULL
ws	NULL
Anti-P-Tyr	NULL
m	NULL
&	NULL
to	NULL
an	NULL
og	NULL
-o	NULL
os	NULL
us	NULL
-MP	NULL
tm	NULL
us	NULL
-s	NULL
as	NULL
on	NULL
a	NULL
Anti-Jak	NULL
1	NULL
C	NULL
Normal	NULL
cDNA	NULL
468+1	NULL
IL4	NULL
/	NULL
-	NULL
+0	NULL
-	NULL
+	NULL
200	NULL
-	NULL
<	NULL
-	NULL
IRS-1	NULL
ww	NULL
»	NULL
«	NULL
t*	NULL
O6	NULL
96	NULL
|	NULL
at	NULL
haman	NULL
:	NULL
IP	NULL
IRS-1	NULL
Blot	NULL
aPY	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK3	NULL
,	NULL
JAK1	NULL
,	NULL
and	NULL
IRS-1	NULL
following	NULL
IL-2	NULL
and	NULL
IL-4	NULL
stimulation	NULL
.	NULL

Normal	NULL
(	NULL
control	NULL
)	NULL
B-LCL	NULL
,	NULL
B-LCL	NULL
derived	NULL
from	NULL
X-SCID	NULL
patients	NULL
with	NULL
various	NULL
y	NULL
,	NULL
mutations	NULL
,	NULL
and	NULL
the	NULL
HUT-78	NULL
T	NULL
cell	NULL
line	NULL
were	NULL
stimulated	NULL
with	NULL
IL-2	NULL
(	NULL
1000	NULL
units/ml	NULL
)	NULL
or	NULL
IL-4	NULL
(	NULL
100	NULL
ng/m	NULL
!	NULL
)	NULL

for	NULL
10	NULL
min	NULL
at	NULL
87	NULL
°C	NULL
.	NULL

X-SCID	NULL
B-LCL	NULL
are	NULL
labeled	NULL
by	NULL
the	NULL
amino	NULL
acid	NULL
position	NULL
of	NULL
their	NULL
mutation	NULL
within	NULL
the	NULL
y	NULL
,	NULL
protein	NULL
,	NULL
except	NULL
for	NULL
the	NULL
B-LCL	NULL
cDNA468+1	NULL
where	NULL
there	NULL
is	NULL
a	NULL
1-base	NULL
pair	NULL
insertion	NULL
at	NULL
position	NULL
468	NULL
of	NULL
the	NULL
y	NULL
,	NULL
cDNA	NULL
.	NULL

The	NULL
ability	NULL
to	NULL
detect	NULL
y	NULL
,	NULL
,	NULL
protein	NULL
in	NULL
each	NULL
cell	NULL
line	NULL
was	NULL
assessed	NULL
by	NULL
immunofluorescence	NULL
with	NULL
an	NULL
anti-y	NULL
,	NULL
monoclonal	NULL
antibody	NULL
(	NULL
7	NULL
,	NULL
IF	NULL
)	NULL
and	NULL
is	NULL
indicated	NULL
as	NULL
either	NULL
normal	NULL
(	NULL
+	NULL
)	NULL
,	NULL
absent	NULL
(	NULL
-	NULL
)	NULL
,	NULL
or	NULL
trace	NULL
(	NULL
Tr	NULL
)	NULL
levels	NULL
.	NULL

Lysates	NULL
were	NULL
immunoprecipitated	NULL
(	NULL
IP	NULL
)	NULL
with	NULL
either	NULL
a	NULL
rabbit	NULL
polyclonal	NULL
anti-JAK3	NULL
antibody	NULL
(	NULL
A	NULL
)	NULL
,	NULL
rabbit	NULL
polyclonal	NULL
anti-JAK1	NULL
antibody	NULL
(	NULL
B	NULL
)	NULL
,	NULL
or	NULL
a	NULL
rabbit	NULL
polyclonal	NULL
anti-IRS-1	NULL
antibody	NULL
(	NULL
C	NULL
)	NULL
,	NULL
resolved	NULL
on	NULL
polyacrylamide	NULL
gels	NULL
,	NULL
and	NULL
immunoblotted	NULL
with	NULL
an	NULL
anti-phosphotyrosine	NULL
monoclonal	NULL
antibody	NULL
(	NULL
aPY	NULL
)	NULL
(	NULL
upper	NULL
panels	NULL
)	NULL
.	NULL

Blots	NULL
were	NULL
then	NULL
stripped	NULL
and	NULL
reprobed	NULL
with	NULL
either	NULL
anti-JAK8	NULL
or	NULL
anti-JAK1	NULL
antibodies	NULL
to	NULL
verify	NULL
equivalent	NULL
levels	NULL
of	NULL
protein	NULL
in	NULL
each	NULL
lane	NULL
(	NULL
ower	NULL
panels	NULL
)	NULL
.	NULL

610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
78316	NULL
Stat6é	NULL
IP	NULL
YclF	NULL
f	NULL
«	NULL
Tr	NULL
we	NULL
``	NULL
Tr	NULL
a	NULL
Control	NULL
924delC	NULL
F227C	NULL
cDNA4GB+1	NULL
R226C	NULL
-	NULL
R224W	NULL
C	NULL
C	NULL
&	NULL
&	NULL
or-	NULL
b	NULL
dive	NULL
or	NULL
tor	NULL
or-	NULL
or	NULL
Pol	NULL
al	NULL
b	NULL
ab	NULL
al	NULL
b	NULL
as	NULL
d	NULL
aas	NULL
d	NULL
a	NULL
al	NULL
d	NULL
a	NULL
)	NULL
a	NULL
=	NULL
!	NULL

=	NULL
=	NULL
=	NULL
=	NULL
=	NULL
=	NULL
!	NULL

=	NULL
=	NULL
!	NULL

=	NULL
!	NULL

=	NULL
!	NULL

=	NULL
#	NULL
@	NULL
=	NULL
-	NULL
@	NULL
-	NULL
@	NULL
-	NULL
eo-	NULL
@	NULL
-	NULL
Anti-P-Tyr	NULL
Anti-Staté	NULL
B	NULL
Normal	NULL
cDNA468+1	NULL
T	NULL
Control	NULL
Ab	NULL
=	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
+	NULL
Anti-STAT6	NULL
-	NULL
-	NULL
4+	NULL
$	NULL
0	NULL
-	NULL
-	NULL
o	NULL
$	NULL
+	NULL
IL-4	NULL
~	NULL
B	NULL
o-	NULL
o	NULL
o-	NULL
ko	NULL
o-	NULL
o	NULL
$	NULL
+	NULL
#	NULL
ﬁl-	NULL
“	NULL
h—	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Analysis	NULL
of	NULL
STAT6	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
DNA	NULL
binding	NULL
activity	NULL
upon	NULL
IL-4	NULL
and	NULL
IL-13	NULL
stimulation	NULL
of	NULL
X-SCID	NULL
B-LCL	NULL
.	NULL

A	NULL
,	NULL
immunoprecipitation	NULL
with	NULL
a	NULL
polyclonal	NULL
anti-STAT6	NULL
antibody	NULL
was	NULL
performed	NULL
on	NULL
lysates	NULL
from	NULL
control	NULL
and	NULL
X-SCID	NULL
B-LCL	NULL
following	NULL
either	NULL
no	NULL
stimulation	NULL
(	NULL
-	NULL
)	NULL
or	NULL
stimulation	NULL
with	NULL
IL-4	NULL
(	NULL
100	NULL
ng/ml	NULL
)	NULL
or	NULL
IL-13	NULL
(	NULL
250	NULL
ng/ml	NULL
)	NULL
for	NULL
10	NULL
min	NULL
at	NULL
37	NULL
°C	NULL
and	NULL
immunoblotted	NULL
with	NULL
anti-phosphotyrosine	NULL
monoclonal	NULL
antibodies	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
.	NULL

Blots	NULL
were	NULL
then	NULL
stripped	NULL
and	NULL
reprobed	NULL
with	NULL
the	NULL
anti-STAT6	NULL
antibody	NULL
to	NULL
monitor	NULL
the	NULL
level	NULL
of	NULL
STAT6	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

B	NULL
,	NULL
whole	NULL
cell	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
``	NULL
°P-labeled	NULL
GAS	NULL
oligonucleotide	NULL
and	NULL
then	NULL
subjected	NULL
to	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
.	NULL

For	NULL
supershift	NULL
reactions	NULL
,	NULL
cells	NULL
were	NULL
preincubated	NULL
with	NULL
either	NULL
an	NULL
anti-STAT6	NULL
antibody	NULL
or	NULL
a	NULL
control	NULL
antibody	NULL
prior	NULL
to	NULL
addition	NULL
of	NULL
probe	NULL
and	NULL
were	NULL
either	NULL
untreated	NULL
(	NULL
-	NULL
)	NULL
or	NULL
stimulated	NULL
with	NULL
IL-4	NULL
(	NULL
+	NULL
)	NULL
.	NULL

tide	NULL
corresponding	NULL
to	NULL
the	NULL
GAS-like	NULL
element	NULL
present	NULL
in	NULL
the	NULL
CD23	NULL
promoter	NULL
(	NULL
5'-AAGACCATTTCTAAGAAATCTATC-3	NULL
'	NULL
)	NULL
(	NULL
83	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
whole	NULL
cell	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
labeled	NULL
probe	NULL
in	NULL
binding	NULL
buffer	NULL
for	NULL
15	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
prior	NULL
to	NULL
electrophoresis	NULL
on	NULL
6	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
and	NULL
autoradiography	NULL
.	NULL

When	NULL
used	NULL
,	NULL
anti-STAT6	NULL
antibodies	NULL
were	NULL
incubated	NULL
with	NULL
cell	NULL
extracts	NULL
for	NULL
15	NULL
min	NULL
following	NULL
the	NULL
addition	NULL
of	NULL
probe	NULL
.	NULL

Analysis	NULL
of	NULL
CD23	NULL
Cell	NULL
Surface	NULL
Expression-For	NULL
flow	NULL
cytometric	NULL
analysis	NULL
of	NULL
surface	NULL
markers	NULL
,	NULL
serum	NULL
was	NULL
removed	NULL
from	NULL
the	NULL
cells	NULL
,	NULL
and	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
with	NULL
or	NULL
without	NULL
IL-4	NULL
for	NULL
48	NULL
h	NULL
at	NULL
a	NULL
density	NULL
of	NULL
5	NULL
X	NULL
10°	NULL
per	NULL
well	NULL
in	NULL
a	NULL
6-well	NULL
plate	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
incubated	NULL
for	NULL
80	NULL
min	NULL
at	NULL
4°C	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
25	NULL
ng	NULL
of	NULL
phycoerythrin-conjugated-EBVCS-5	NULL
(	NULL
anti-human	NULL
CD23	NULL
,	NULL
IgG1	NULL
)	NULL
or	NULL
an	NULL
isotype	NULL
control	NULL
.	NULL

CD23	NULL
surface	NULL
staining	NULL
was	NULL
measured	NULL
using	NULL
a	NULL
FACscan	NULL
flow	NULL
cytometer	NULL
,	NULL
and	NULL
the	NULL
data	NULL
were	NULL
analyzed	NULL
with	NULL
Cellquest	NULL
software	NULL
(	NULL
Becton-Dickinson	NULL
,	NULL
San	NULL
Jose	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
mean	NULL
fluorescence	NULL
intensities	NULL
were	NULL
calculated	NULL
by	NULL
deducting	NULL
the	NULL
corresponding	NULL
isotype	NULL
control	NULL
.	NULL

IL-4	NULL
Signaling	NULL
in	NULL
X-SCID	NULL
B	NULL
Cells	NULL
IP	NULL
STAT6	NULL
Blot	NULL
«	NULL
PY	NULL
la	NULL
[	NULL
-x	NULL
-	NULL
4	NULL
-	NULL
#	NULL
200	NULL
96—	NULL
``	NULL
``	NULL
@	NULL
»	NULL
MM	NULL
<	NULL
-srats	NULL
°-	NULL
aalcal	NULL
Normal	NULL
cDNA	NULL
cDNA	NULL
468+1	NULL
468+1	NULL
Blot	NULL
a	NULL
STATE	NULL
-s	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

STAT6	NULL
phosphorylation	NULL
is	NULL
enhanced	NULL
following	NULL
y	NULL
,	NULL
reconstitution	NULL
of	NULL
an	NULL
X-SCID	NULL
B-LCL	NULL
.	NULL

Immunoprecipitation	NULL
with	NULL
a	NULL
polyclonal	NULL
anti-STAT6	NULL
antibody	NULL
was	NULL
performed	NULL
on	NULL
lysates	NULL
from	NULL
a	NULL
control	NULL
(	NULL
normal	NULL
)	NULL
,	NULL
X-SCID	NULL
B-LCL	NULL
(	NULL
eDNA468+1	NULL
)	NULL
,	NULL
and	NULL
the	NULL
same	NULL
X-SCID	NULL
B-LCL	NULL
reconstituted	NULL
with	NULL
y	NULL
,	NULL
(	NULL
XSCID+y	NULL
,	NULL
)	NULL
following	NULL
either	NULL
no	NULL
stimulation	NULL
(	NULL
-	NULL
)	NULL
or	NULL
stimulation	NULL
with	NULL
IL-4	NULL
(	NULL
+	NULL
)	NULL
.	NULL

Immunoprecipitates	NULL
were	NULL
blotted	NULL
with	NULL
anti-phosphotyrosine	NULL
monoclonal	NULL
antibodies	NULL
(	NULL
upper	NULL
panel	NULL
!	NULL
)	NULL

and	NULL
reprobed	NULL
with	NULL
an	NULL
anti-STAT6	NULL
antibody	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

RESULTS	NULL
JAK1	NULL
and	NULL
IRS-1	NULL
,	NULL
but	NULL
Not	NULL
JAK3	NULL
,	NULL
Are	NULL
Phosphorylated	NULL
following	NULL
IL-4	NULL
Stimulation	NULL
of	NULL
X-SCID	NULL
B-LCL-In	NULL
order	NULL
to	NULL
investigate	NULL
whether	NULL
there	NULL
is	NULL
any	NULL
y	NULL
,	NULL
-independent	NULL
cytokine-mediated	NULL
signal	NULL
transduction	NULL
in	NULL
X-SCID	NULL
B	NULL
cells	NULL
,	NULL
we	NULL
assessed	NULL
the	NULL
phosphorylation	NULL
of	NULL
the	NULL
major	NULL
intermediates	NULL
determined	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
IL-4	NULL
signaling	NULL
.	NULL

JAK3	NULL
associates	NULL
with	NULL
the	NULL
shared	NULL
y	NULL
,	NULL
subunit	NULL
of	NULL
the	NULL
IL-2	NULL
and	NULL
IL-4	NULL
receptors	NULL
and	NULL
is	NULL
tyrosine-phosphorylated	NULL
upon	NULL
addition	NULL
of	NULL
either	NULL
cytokine	NULL
(	NULL
14-17	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
analyzed	NULL
JAK3	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
response	NULL
to	NULL
IL-2	NULL
and	NULL
IL-4	NULL
stimulation	NULL
in	NULL
Epstein-Barr	NULL
virus-	NULL
transformed	NULL
X-SCID	NULL
B-LCL	NULL
with	NULL
heterogeneous	NULL
y	NULL
,	NULL
mutations	NULL
.	NULL

Although	NULL
JAK3	NULL
was	NULL
tyrosine-phosphorylated	NULL
upon	NULL
both	NULL
IL-2	NULL
and	NULL
IL-4	NULL
stimulation	NULL
of	NULL
a	NULL
control	NULL
B-LCL	NULL
and	NULL
the	NULL
HUT78	NULL
T	NULL
cell	NULL
line	NULL
,	NULL
we	NULL
did	NULL
not	NULL
detect	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK3	NULL
following	NULL
IL-2	NULL
or	NULL
IL-4	NULL
stimulation	NULL
of	NULL
any	NULL
of	NULL
the	NULL
X-SCID	NULL
B-LCLs	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
,	NULL
upper	NULL
panel	NULL
)	NULL
.	NULL

Equivalent	NULL
levels	NULL
of	NULL
immunoprecipitated	NULL
JAK3	NULL
could	NULL
be	NULL
demonstrated	NULL
in	NULL
each	NULL
lane	NULL
by	NULL
immunoblotting	NULL
the	NULL
same	NULL
filter	NULL
with	NULL
a	NULL
polyclonal	NULL
anti-JAK3	NULL
antibody	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
JAK3	NULL
is	NULL
not	NULL
phosphorylated	NULL
following	NULL
IL-2	NULL
or	NULL
IL-4	NULL
stimulation	NULL
of	NULL
X-SCID	NULL
B-LCL	NULL
with	NULL
a	NULL
diversity	NULL
of	NULL
y	NULL
,	NULL
mutations	NULL
(	NULL
28	NULL
,	NULL
29	NULL
,	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

JAK1	NULL
constitutively	NULL
associates	NULL
with	NULL
the	NULL
IL-2R§	NULL
and	NULL
IL-4Ra	NULL
subunits	NULL
of	NULL
the	NULL
IL-2	NULL
and	NULL
IL-4	NULL
receptors	NULL
,	NULL
respectively	NULL
,	NULL
and	NULL
is	NULL
phosphorylated	NULL
upon	NULL
receptor	NULL
stimulation	NULL
(	NULL
14	NULL
,	NULL
16	NULL
,	NULL
34	NULL
)	NULL
.	NULL

It	NULL
might	NULL
be	NULL
predicted	NULL
that	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
JAK3	NULL
phosphorylation	NULL
,	NULL
JAK1	NULL
would	NULL
not	NULL
be	NULL
phosphorylated	NULL
in	NULL
response	NULL
to	NULL
IL-2	NULL
or	NULL
IL-4	NULL
in	NULL
X-SCID	NULL
B-LCL	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
JAK1	NULL
was	NULL
not	NULL
phosphorylated	NULL
in	NULL
any	NULL
of	NULL
the	NULL
X-SCID	NULL
B-LCLs	NULL
tested	NULL
following	NULL
the	NULL
addition	NULL
of	NULL
IL-2	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
upper	NULL
panel	NULL
)	NULL
.	NULL

However	NULL
,	NULL
treatment	NULL
with	NULL
IL-4	NULL
resulted	NULL
in	NULL
JAK1	NULL
phosphorylation	NULL
in	NULL
all	NULL
X-SCID	NULL
B-LCLs	NULL
.	NULL

It	NULL
is	NULL
of	NULL
interest	NULL
to	NULL
note	NULL
that	NULL
the	NULL
phosphorylation	NULL
of	NULL
JAK1	NULL
was	NULL
observed	NULL
irrespective	NULL
of	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
y	NULL
,	NULL
subunit	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
the	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
IL-4	NULL
Signaling	NULL
in	NULL
X-SCID	NULL
B	NULL
Cells	NULL
Normal	NULL
X-SCID	NULL
7317	NULL
x-SCID/ye	NULL
Number	NULL
Cell	NULL
Fluorescence	NULL
Intensity	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Modulation	NULL
of	NULL
CD23	NULL
cell	NULL
surface	NULL
expression	NULL
by	NULL
IL-4	NULL
.	NULL

Normal	NULL
,	NULL
X-SCID	NULL
,	NULL
and	NULL
y	NULL
-reconstituted	NULL
B	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
or	NULL
without	NULL
IL-4	NULL
in	NULL
serum-free	NULL
conditions	NULL
for	NULL
48	NULL
h.	NULL
CD23	NULL
expression	NULL
was	NULL
measured	NULL
by	NULL
fluorescence-activated	NULL
cell	NULL
sorting	NULL
as	NULL
described	NULL
.	NULL

Expression	NULL
in	NULL
untreated	NULL
and	NULL
IL-4-stimulated	NULL
cells	NULL
are	NULL
shown	NULL
as	NULL
open	NULL
and	NULL
closed	NULL
histograms	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
mean	NULL
fluorescence	NULL
intensity	NULL
of	NULL
CD23	NULL
on	NULL
the	NULL
cell	NULL
surface	NULL
,	NULL
with	NULL
or	NULL
without	NULL
IL-4	NULL
stimulation	NULL
,	NULL
was	NULL
analyzed	NULL
with	NULL
Cellquest	NULL
software	NULL
(	NULL
Becton-Dickinson	NULL
)	NULL
.	NULL

The	NULL
mean	NULL
fluorescence	NULL
intensity	NULL
in	NULL
the	NULL
normal	NULL
,	NULL
X-SCID	NULL
,	NULL
and	NULL
y	NULL
,	NULL
reconstituted	NULL
X-SCID	NULL
B-LCL	NULL
increased	NULL
by	NULL
1.98	NULL
(	NULL
170.836	NULL
to	NULL
330.09	NULL
)	NULL
,	NULL
1.00	NULL
(	NULL
188.45	NULL
to	NULL
181.76	NULL
)	NULL
,	NULL
and	NULL
1.48	NULL
(	NULL
282.56	NULL
to	NULL
344.91	NULL
)	NULL
-fold	NULL
,	NULL
respectively	NULL
.	NULL

Results	NULL
are	NULL
representative	NULL
of	NULL
data	NULL
from	NULL
four	NULL
independent	NULL
experiments	NULL
.	NULL

X-SCID	NULL
B-LCL	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
JAK1	NULL
is	NULL
activated	NULL
by	NULL
an	NULL
IL-4-responsive	NULL
pathway	NULL
in	NULL
X-SCID	NULL
B-LCL	NULL
which	NULL
is	NULL
independent	NULL
of	NULL
y	NULL
,	NULL
and	NULL
JAK3	NULL
.	NULL

The	NULL
large	NULL
cytosolic	NULL
docking	NULL
molecule	NULL
IRS-1	NULL
is	NULL
also	NULL
tyrosine-phosphorylated	NULL
in	NULL
response	NULL
to	NULL
IL-4	NULL
and	NULL
has	NULL
been	NULL
hypothesized	NULL
to	NULL
be	NULL
important	NULL
for	NULL
an	NULL
IL-4-mediated	NULL
proliferative	NULL
response	NULL
(	NULL
35	NULL
,	NULL
36	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
examined	NULL
the	NULL
effects	NULL
of	NULL
IL-4	NULL
on	NULL
IRS-1	NULL
phosphorylation	NULL
in	NULL
X-SCID	NULL
B	NULL
cells	NULL
.	NULL

Following	NULL
immunoprecipitation	NULL
with	NULL
specific	NULL
antibodies	NULL
,	NULL
we	NULL
detected	NULL
IL-4-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
IRS-1	NULL
in	NULL
both	NULL
B-LCL	NULL
from	NULL
a	NULL
normal	NULL
donor	NULL
and	NULL
a	NULL
patient	NULL
with	NULL
X-SCID	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
y	NULL
,	NULL
expression	NULL
is	NULL
not	NULL
required	NULL
for	NULL
IL-4-mediated	NULL
IRS-1	NULL
phosphorylation	NULL
.	NULL

IL-4	NULL
and	NULL
IL-13	NULL
Induce	NULL
STAT6	NULL
Phosphorylation	NULL
and	NULL
Activation	NULL
in	NULL
X-SCID	NULL
B-LCL-Stimulation	NULL
of	NULL
many	NULL
cell	NULL
types	NULL
with	NULL
IL-4	NULL
leads	NULL
to	NULL
the	NULL
phosphorylation	NULL
of	NULL
STAT6	NULL
(	NULL
87	NULL
)	NULL
.	NULL

As	NULL
JAKB3	NULL
was	NULL
not	NULL
phosphorylated	NULL
in	NULL
X-SCID	NULL
B	NULL
cells	NULL
,	NULL
it	NULL
was	NULL
important	NULL
to	NULL
determine	NULL
whether	NULL
IL-4-mediated	NULL
STAT6	NULL
phosphorylation	NULL
would	NULL
also	NULL
be	NULL
affected	NULL
by	NULL
the	NULL
loss	NULL
of	NULL
y	NULL
,	NULL
,	NULL
.	NULL

Previous	NULL
data	NULL
indicated	NULL
that	NULL
IL-13	NULL
,	NULL
which	NULL
shares	NULL
many	NULL
structural	NULL
and	NULL
functional	NULL
characteristics	NULL
with	NULL
IL-4	NULL
(	NULL
38-40	NULL
)	NULL
,	NULL
but	NULL
not	NULL
IL-4	NULL
itself	NULL
,	NULL
induced	NULL
STAT6	NULL
activation	NULL
in	NULL
X-SCID	NULL
B-LCL	NULL
(	NULL
25	NULL
)	NULL
.	NULL

However	NULL
,	NULL
we	NULL
found	NULL
that	NULL
STAT6	NULL
was	NULL
tyrosine-phosphorylated	NULL
upon	NULL
both	NULL
IL-4	NULL
and	NULL
IL-13	NULL
stimulation	NULL
in	NULL
every	NULL
X-SCID	NULL
B-LCL	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

Nevertheless	NULL
,	NULL
the	NULL
IL-4-stimulated	NULL
phosphorylation	NULL
of	NULL
STAT6	NULL
was	NULL
significantly	NULL
greater	NULL
in	NULL
control	NULL
B-LCL	NULL
than	NULL
in	NULL
all	NULL
X-SCID	NULL
B-LCL	NULL
tested	NULL
(	NULL
Figs	NULL
.	NULL

2A	NULL
and	NULL
3	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
IL-13-mediated	NULL
stimulation	NULL
of	NULL
STAT6	NULL
was	NULL
roughly	NULL
equivalent	NULL
among	NULL
the	NULL
control	NULL
and	NULL
X-SCID	NULL
B-LCLs	NULL
.	NULL

We	NULL
also	NULL
found	NULL
that	NULL
IL-4	NULL
stimulated	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
control	NULL
and	NULL
X-SCID	NULL
B-LCL	NULL
as	NULL
assessed	NULL
by	NULL
an	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Since	NULL
IL-4	NULL
is	NULL
known	NULL
to	NULL
induce	NULL
the	NULL
expression	NULL
of	NULL
CD23	NULL
in	NULL
B	NULL
cells	NULL
(	NULL
41	NULL
)	NULL
,	NULL
we	NULL
assessed	NULL
DNA	NULL
binding	NULL
activity	NULL
with	NULL
a	NULL
probe	NULL
corresponding	NULL
to	NULL
the	NULL
interferon-y	NULL
activation	NULL
sequence	NULL
(	NULL
GAS	NULL
)	NULL
element	NULL
in	NULL
the	NULL
CD23	NULL
promoter	NULL
(	NULL
42	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
gel-retarded	NULL
CD23	NULL
GAS	NULL
element-binding	NULL
complexes	NULL
were	NULL
formed	NULL
following	NULL
IL-4	NULL
stimulation	NULL
of	NULL
both	NULL
a	NULL
control	NULL
B-LCL	NULL
as	NULL
well	NULL
as	NULL
an	NULL
X-SCID	NULL
B-LCL	NULL
(	NULL
cDNA468+1	NULL
)	NULL
.	NULL

However	NULL
,	NULL
as	NULL
might	NULL
be	NULL
expected	NULL
from	NULL
our	NULL
finding	NULL
that	NULL
STAT6	NULL
was	NULL
phosphorylated	NULL
at	NULL
lower	NULL
levels	NULL
in	NULL
IL-4-stimulated	NULL
X-SCID	NULL
B-LCL	NULL
as	NULL
compared	NULL
with	NULL
control	NULL
B-LCL	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
,	NULL
IL-4-induced	NULL
DNA	NULL
binding	NULL
activity	NULL
was	NULL
significantly	NULL
lower	NULL
in	NULL
all	NULL
X-SCID	NULL
B-LCL	NULL
than	NULL
in	NULL
control	NULL
B-LCL	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
ascertain	NULL
whether	NULL
the	NULL
DNA	NULL
binding	NULL
complexes	NULL
contained	NULL
STAT6	NULL
,	NULL
we	NULL
performed	NULL
supershift	NULL
analyses	NULL
using	NULL
STAT6	NULL
anti-sera	NULL
.	NULL

In	NULL
each	NULL
of	NULL
the	NULL
IL-4-induced	NULL
DNA	NULL
binding	NULL
complexes	NULL
,	NULL
a	NULL
supershift	NULL
was	NULL
detected	NULL
using	NULL
STAT6	NULL
antisera	NULL
but	NULL
not	NULL
with	NULL
a	NULL
control	NULL
rabbit	NULL
antisera	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

This	NULL
demonstration	NULL
of	NULL
IL-4-stimulated	NULL
STAT6	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
cells	NULL
that	NULL
do	NULL
not	NULL
express	NULL
y	NULL
,	NULL
further	NULL
supports	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
IL-4	NULL
signaling	NULL
pathway	NULL
independent	NULL
of	NULL
y	NULL
,	NULL
,	NULL
and	NULL
JAK3	NULL
.	NULL

STAT6	NULL
Phosphorylation	NULL
and	NULL
DNA	NULL
Binding	NULL
Activity	NULL
Are	NULL
Enhanced	NULL
following	NULL
Reconstitution	NULL
of	NULL
an	NULL
X-SCID	NULL
B-LCL	NULL
with	NULL
Wild	NULL
Type	NULL
y-In	NULL
order	NULL
to	NULL
determine	NULL
the	NULL
role	NULL
of	NULL
y	NULL
,	NULL
in	NULL
IL-4-mediated	NULL
signaling	NULL
,	NULL
we	NULL
assessed	NULL
STAT6	NULL
phosphorylation	NULL
and	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
an	NULL
X-SCID	NULL
B-LCL	NULL
in	NULL
which	NULL
y	NULL
,	NULL
,	NULL
expression	NULL
was	NULL
reconstituted	NULL
using	NULL
retroviral	NULL
mediated	NULL
gene	NULL
transduction	NULL
(	NULL
30	NULL
)	NULL
.	NULL

The	NULL
data	NULL
presented	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
demonstrate	NULL
that	NULL
IL-4-mediated	NULL
STAT6	NULL
phosphorylation	NULL
was	NULL
significantly	NULL
enhanced	NULL
in	NULL
the	NULL
y	NULL
,	NULL
,	NULL
reconstituted	NULL
X-SCID	NULL
B-LCL	NULL
,	NULL
approaching	NULL
the	NULL
level	NULL
observed	NULL
in	NULL
the	NULL
control	NULL
B	NULL
cell	NULL
line	NULL
.	NULL

Moreover	NULL
,	NULL
anti-STAT6	NULL
supershifted	NULL
DNA	NULL
binding	NULL
complexes	NULL
induced	NULL
by	NULL
IL-4	NULL
were	NULL
more	NULL
abundant	NULL
in	NULL
y	NULL
,	NULL
reconstituted	NULL
X-SCID	NULL
B-LCL	NULL
than	NULL
in	NULL
the	NULL
X-SCID	NULL
B-LCL	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
wild	NULL
type	NULL
levels	NULL
of	NULL
STAT6	NULL
phosphorylation	NULL
and	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
control	NULL
B-LCL	NULL
are	NULL
likely	NULL
due	NULL
to	NULL
significant	NULL
transduction	NULL
through	NULL
the	NULL
y	NULL
-dependent	NULL
IL-4	NULL
pathway	NULL
.	NULL

IL-4-induced	NULL
Regulation	NULL
of	NULL
CD23	NULL
Expression	NULL
in	NULL
X-SCID	NULL
and	NULL
y	NULL
,	NULL
,	NULL
Reconstituted	NULL
B-LCL-Our	NULL
data	NULL
indicate	NULL
that	NULL
JAK1	NULL
,	NULL
STAT6	NULL
,	NULL
and	NULL
IRS-1	NULL
can	NULL
be	NULL
phosphorylated	NULL
by	NULL
IL-4	NULL
in	NULL
a	NULL
y.	NULL
,	NULL
-independent	NULL
fashion	NULL
.	NULL

However	NULL
,	NULL
it	NULL
was	NULL
not	NULL
clear	NULL
whether	NULL
these	NULL
IL-4-mediated	NULL
biochemical	NULL
responses	NULL
in	NULL
B	NULL
cells	NULL
derived	NULL
from	NULL
X-SCID	NULL
patients	NULL
would	NULL
result	NULL
in	NULL
biological	NULL
outcomes	NULL
,	NULL
such	NULL
as	NULL
changes	NULL
in	NULL
gene	NULL
expression	NULL
in	NULL
X-SCID	NULL
B	NULL
cells	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
IL-4	NULL
induces	NULL
CD23	NULL
(	NULL
FeeRII	NULL
)	NULL
antigen	NULL
expression	NULL
in	NULL
normal	NULL
mature	NULL
B	NULL
cells	NULL
(	NULL
10	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
determine	NULL
whether	NULL
y	NULL
,	NULL
expression	NULL
had	NULL
a	NULL
significant	NULL
effect	NULL
on	NULL
IL-4	NULL
functional	NULL
responses	NULL
,	NULL
IL-4-induced	NULL
regulation	NULL
of	NULL
CD23	NULL
in	NULL
normal	NULL
,	NULL
X-SCID	NULL
,	NULL
and	NULL
y	NULL
,	NULL
reconstituted	NULL
X-SCID	NULL
B-LCL	NULL
was	NULL
examined	NULL
.	NULL

A	NULL
48-h	NULL
incubation	NULL
of	NULL
control	NULL
B	NULL
cells	NULL
with	NULL
IL-4	NULL
resulted	NULL
in	NULL
an	NULL
almost	NULL
2-fold	NULL
increase	NULL
in	NULL
CD23	NULL
levels	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
,	NULL
whereas	NULL
no	NULL
changes	NULL
in	NULL
CD23	NULL
expression	NULL
were	NULL
detected	NULL
in	NULL
B-LCL	NULL
derived	NULL
from	NULL
a	NULL
number	NULL
of	NULL
patients	NULL
.	NULL

However	NULL
,	NULL
in	NULL
X-SCID	NULL
cells	NULL
reconstituted	NULL
with	NULL
y	NULL
,	NULL
,	NULL
there	NULL
was	NULL
an	NULL
almost	NULL
2-fold	NULL
increase	NULL
of	NULL
CD23	NULL
levels	NULL
when	NULL
compared	NULL
with	NULL
the	NULL
same	NULL
cells	NULL
incubated	NULL
without	NULL
IL-4	NULL
.	NULL

This	NULL
was	NULL
a	NULL
consistent	NULL
finding	NULL
in	NULL
four	NULL
replicate	NULL
experiments	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
y	NULL
,	NULL
is	NULL
important	NULL
for	NULL
transducing	NULL
some	NULL
of	NULL
the	NULL
functional	NULL
responses	NULL
to	NULL
IL-4	NULL
.	NULL

610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
7318	NULL
DISCUSSION	NULL
Stimulation	NULL
of	NULL
B	NULL
cells	NULL
with	NULL
IL-4	NULL
results	NULL
in	NULL
proliferation	NULL
,	NULL
immunoglobulin	NULL
class	NULL
switching	NULL
,	NULL
and	NULL
regulation	NULL
of	NULL
cell	NULL
surface	NULL
proteins	NULL
such	NULL
as	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II	NULL
molecules	NULL
and	NULL
the	NULL
CD23	NULL
receptor	NULL
.	NULL

Previous	NULL
reports	NULL
have	NULL
concluded	NULL
that	NULL
the	NULL
JAK-STAT	NULL
pathway	NULL
is	NULL
not	NULL
activated	NULL
by	NULL
IL-4	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
y	NULL
,	NULL
(	NULL
25	NULL
,	NULL
26	NULL
)	NULL
.	NULL

However	NULL
,	NULL
IL-4	NULL
can	NULL
induce	NULL
functional	NULL
,	NULL
although	NULL
suboptimal	NULL
,	NULL
responses	NULL
in	NULL
X-SCID	NULL
B	NULL
cells	NULL
(	NULL
27	NULL
)	NULL
suggesting	NULL
that	NULL
the	NULL
IL-4	NULL
signal	NULL
transduction	NULL
pathway	NULL
is	NULL
conserved	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

X-SCID	NULL
B	NULL
cells	NULL
,	NULL
therefore	NULL
,	NULL
provide	NULL
an	NULL
important	NULL
model	NULL
in	NULL
which	NULL
to	NULL
examine	NULL
the	NULL
generation	NULL
of	NULL
y.-independent	NULL
IL-4	NULL
responses	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
determined	NULL
that	NULL
JAK1	NULL
,	NULL
IRS-1	NULL
,	NULL
and	NULL
STAT6	NULL
were	NULL
tyrosine-phosphorylated	NULL
in	NULL
response	NULL
to	NULL
IL-4	NULL
in	NULL
B	NULL
cell	NULL
lines	NULL
derived	NULL
from	NULL
X-SCID	NULL
patients	NULL
with	NULL
a	NULL
wide	NULL
diversity	NULL
of	NULL
y	NULL
,	NULL
mutations	NULL
and	NULL
that	NULL
IL-4	NULL
induced	NULL
detectable	NULL
levels	NULL
of	NULL
STAT6	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

The	NULL
finding	NULL
that	NULL
JAK3	NULL
was	NULL
not	NULL
phosphorylated	NULL
in	NULL
X-SCID	NULL
B-LCL	NULL
stimulated	NULL
with	NULL
either	NULL
IL-2	NULL
or	NULL
IL-4	NULL
was	NULL
not	NULL
surprising	NULL
as	NULL
a	NULL
number	NULL
of	NULL
recent	NULL
studies	NULL
have	NULL
demonstrated	NULL
a	NULL
physical	NULL
association	NULL
between	NULL
y	NULL
,	NULL
and	NULL
JAK3	NULL
(	NULL
14	NULL
,	NULL
16	NULL
)	NULL
.	NULL

This	NULL
interaction	NULL
is	NULL
thought	NULL
to	NULL
be	NULL
critical	NULL
for	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
IL-7	NULL
,	NULL
IL-9	NULL
,	NULL
and	NULL
IL-15	NULL
signaling	NULL
in	NULL
lymphocytes	NULL
(	NULL
14	NULL
,	NULL
16	NULL
,	NULL
43	NULL
)	NULL
.	NULL

The	NULL
data	NULL
described	NULL
here	NULL
show	NULL
that	NULL
IL-4-induced	NULL
JAK1	NULL
and	NULL
IRS-1	NULL
phosphorylation	NULL
as	NULL
well	NULL
as	NULL
STAT6	NULL
activation	NULL
can	NULL
occur	NULL
via	NULL
mechanisms	NULL
that	NULL
are	NULL
independent	NULL
of	NULL
y	NULL
,	NULL
and	NULL
JAK3	NULL
.	NULL

IRS-1	NULL
is	NULL
thought	NULL
to	NULL
be	NULL
important	NULL
for	NULL
mediating	NULL
IL-4	NULL
proliferative	NULL
effects	NULL
,	NULL
but	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
IL-4	NULL
stimulates	NULL
IRS-1	NULL
phosphorylation	NULL
is	NULL
unclear	NULL
(	NULL
44	NULL
)	NULL
.	NULL

Janus	NULL
kinases	NULL
likely	NULL
play	NULL
an	NULL
important	NULL
role	NULL
(	NULL
45	NULL
)	NULL
,	NULL
and	NULL
our	NULL
data	NULL
suggest	NULL
that	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
JAK3	NULL
,	NULL
JAK1	NULL
may	NULL
mediate	NULL
IRS-1	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
response	NULL
to	NULL
IL-4	NULL
.	NULL

It	NULL
remains	NULL
to	NULL
be	NULL
determined	NULL
whether	NULL
other	NULL
tyrosine	NULL
kinases	NULL
known	NULL
to	NULL
be	NULL
induced	NULL
by	NULL
IL-4	NULL
,	NULL
including	NULL
JAK2	NULL
,	NULL
Tyk2	NULL
,	NULL
and	NULL
Fes	NULL
(	NULL
46-48	NULL
)	NULL
,	NULL
play	NULL
a	NULL
role	NULL
in	NULL
IL-4-mediated	NULL
responses	NULL
in	NULL
X-SCID	NULL
B	NULL
cells	NULL
.	NULL

Matthews	NULL
et	NULL
al	NULL
.	NULL

(	NULL
27	NULL
)	NULL
showed	NULL
that	NULL
functional	NULL
responses	NULL
such	NULL
as	NULL
proliferation	NULL
,	NULL
IgE	NULL
secretion	NULL
,	NULL
and	NULL
CD23	NULL
expression	NULL
could	NULL
occur	NULL
in	NULL
X-SCID	NULL
B	NULL
cells	NULL
when	NULL
co-stimulated	NULL
in	NULL
vitro	NULL
by	NULL
IL-4	NULL
or	NULL
IL-13	NULL
together	NULL
with	NULL
CD4OL	NULL
or	NULL
IgM	NULL
.	NULL

However	NULL
,	NULL
in	NULL
our	NULL
studies	NULL
,	NULL
we	NULL
did	NULL
not	NULL
detect	NULL
an	NULL
increase	NULL
in	NULL
CD23	NULL
expression	NULL
in	NULL
X-SCID	NULL
B-LCL	NULL
even	NULL
though	NULL
CD23	NULL
expression	NULL
did	NULL
increase	NULL
in	NULL
normal	NULL
and	NULL
y	NULL
freconstituted	NULL
X-SCID	NULL
B-LCL	NULL
following	NULL
stimulation	NULL
with	NULL
IL-4	NULL
.	NULL

Because	NULL
of	NULL
the	NULL
already	NULL
high	NULL
level	NULL
of	NULL
CD23	NULL
expression	NULL
on	NULL
Epstein-Barr	NULL
virus-transformed	NULL
B	NULL
cells	NULL
,	NULL
slight	NULL
increases	NULL
in	NULL
CD23	NULL
expression	NULL
may	NULL
be	NULL
difficult	NULL
to	NULL
detect	NULL
.	NULL

Nevertheless	NULL
,	NULL
even	NULL
in	NULL
the	NULL
studies	NULL
performed	NULL
by	NULL
Matthews	NULL
et	NULL
al	NULL
.	NULL

(	NULL
27	NULL
)	NULL
in	NULL
primary	NULL
B	NULL
cells	NULL
,	NULL
the	NULL
increase	NULL
in	NULL
CD23	NULL
in	NULL
X-SCID	NULL
B	NULL
cells	NULL
was	NULL
significantly	NULL
lower	NULL
than	NULL
that	NULL
detected	NULL
in	NULL
control	NULL
B	NULL
cells	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Suboptimal	NULL
CD23	NULL
activation	NULL
in	NULL
response	NULL
to	NULL
IL-4	NULL
suggests	NULL
that	NULL
the	NULL
observed	NULL
humoral	NULL
deficiency	NULL
in	NULL
X-SCID	NULL
patients	NULL
may	NULL
result	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
from	NULL
the	NULL
inability	NULL
to	NULL
transduce	NULL
the	NULL
full	NULL
set	NULL
of	NULL
IL-4-induced	NULL
signals	NULL
through	NULL
non-y	NULL
,	NULL
,	NULL
containing	NULL
receptors	NULL
.	NULL

Our	NULL
finding	NULL
that	NULL
IL-4-induced	NULL
STAT6	NULL
phosphorylation	NULL
and	NULL
CD23	NULL
expression	NULL
were	NULL
restored	NULL
to	NULL
wild	NULL
type	NULL
levels	NULL
following	NULL
introduction	NULL
of	NULL
y	NULL
,	NULL
,	NULL
into	NULL
these	NULL
cells	NULL
indicates	NULL
that	NULL
y	NULL
,	NULL
potentiates	NULL
the	NULL
IL-4	NULL
signal	NULL
transduction	NULL
pathway	NULL
.	NULL

The	NULL
importance	NULL
of	NULL
JAK3	NULL
in	NULL
this	NULL
y.-de-pendent	NULL
pathway	NULL
is	NULL
further	NULL
supported	NULL
by	NULL
the	NULL
recent	NULL
observation	NULL
that	NULL
IL-4-induced	NULL
CD23	NULL
expression	NULL
and	NULL
STAT6	NULL
activation	NULL
are	NULL
also	NULL
suboptimal	NULL
in	NULL
B	NULL
cells	NULL
that	NULL
express	NULL
y	NULL
,	NULL
,	NULL
but	NULL
are	NULL
deficient	NULL
in	NULL
JAK3	NULL
(	NULL
49	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
precise	NULL
mechanism	NULL
by	NULL
which	NULL
this	NULL
y	NULL
,	NULL
-independent	NULL
signaling	NULL
pathway	NULL
is	NULL
initiated	NULL
is	NULL
not	NULL
clear	NULL
,	NULL
several	NULL
groups	NULL
have	NULL
previously	NULL
shown	NULL
IL-4-induced	NULL
proliferation	NULL
and	NULL
protein	NULL
phosphorylation	NULL
in	NULL
endothelial	NULL
,	NULL
colon	NULL
carcinoma	NULL
,	NULL
and	NULL
plasmo-cytoma	NULL
cell	NULL
lines	NULL
that	NULL
lack	NULL
y	NULL
,	NULL
(	NULL
27	NULL
,	NULL
46	NULL
,	NULL
47	NULL
,	NULL
50-52	NULL
)	NULL
.	NULL

The	NULL
y	NULL
,	NULL
-independent	NULL
pathway	NULL
in	NULL
these	NULL
cells	NULL
has	NULL
been	NULL
suggested	NULL
to	NULL
function	NULL
through	NULL
a	NULL
receptor	NULL
that	NULL
is	NULL
shared	NULL
by	NULL
IL-4	NULL
and	NULL
IL-13	NULL
since	NULL
antibodies	NULL
to	NULL
the	NULL
IL-4Ra	NULL
chain	NULL
can	NULL
block	NULL
the	NULL
binding	NULL
and	NULL
IL-4	NULL
Signaling	NULL
in	NULL
X-SCID	NULL
B	NULL
Cells	NULL
function	NULL
of	NULL
IL-4	NULL
as	NULL
well	NULL
as	NULL
IL-13	NULL
(	NULL
53-57	NULL
)	NULL
.	NULL

Accordingly	NULL
,	NULL
IL-4	NULL
and	NULL
IL-13	NULL
stimulate	NULL
the	NULL
phosphorylation	NULL
of	NULL
many	NULL
of	NULL
the	NULL
same	NULL
downstream	NULL
substrates	NULL
(	NULL
47	NULL
,	NULL
51	NULL
,	NULL
55	NULL
,	NULL
58-60	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
IL-13	NULL
receptor	NULL
subunits	NULL
that	NULL
have	NULL
varied	NULL
capacities	NULL
to	NULL
bind	NULL
IL-4	NULL
have	NULL
recently	NULL
been	NULL
identified	NULL
(	NULL
61	NULL
,	NULL
62	NULL
)	NULL
.	NULL

Our	NULL
data	NULL
support	NULL
common	NULL
signaling	NULL
mechanisms	NULL
as	NULL
IL-4-activated	NULL
JAK1	NULL
and	NULL
STAT6	NULL
but	NULL
not	NULL
JAK3	NULL
in	NULL
X-SCID	NULL
B	NULL
cells	NULL
,	NULL
and	NULL
this	NULL
concurs	NULL
with	NULL
what	NULL
has	NULL
been	NULL
reported	NULL
for	NULL
IL-13	NULL
(	NULL
47	NULL
,	NULL
51	NULL
58	NULL
,	NULL
60	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
an	NULL
IL-4-mediated	NULL
signal	NULL
transduction	NULL
pathway	NULL
in	NULL
y	NULL
,	NULL
-deficient	NULL
X-SCID	NULL
cells	NULL
may	NULL
occur	NULL
via	NULL
the	NULL
same	NULL
mechanisms	NULL
utilized	NULL
by	NULL
IL-13	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
other	NULL
forms	NULL
of	NULL
SCID	NULL
that	NULL
present	NULL
with	NULL
a	NULL
complete	NULL
absence	NULL
of	NULL
both	NULL
T	NULL
and	NULL
B	NULL
lymphocytes	NULL
,	NULL
X-SCID	NULL
patients	NULL
have	NULL
normal	NULL
to	NULL
elevated	NULL
numbers	NULL
of	NULL
nonfunctional	NULL
B	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
clear	NULL
that	NULL
the	NULL
IL-4	NULL
signaling	NULL
that	NULL
we	NULL
have	NULL
detected	NULL
is	NULL
not	NULL
sufficient	NULL
for	NULL
normal	NULL
B	NULL
cell	NULL
function	NULL
.	NULL

The	NULL
findings	NULL
presented	NULL
here	NULL
provide	NULL
insight	NULL
into	NULL
IL-4	NULL
signal	NULL
transduction	NULL
pathways	NULL
and	NULL
B	NULL
cell	NULL
function	NULL
in	NULL
X-SCID	NULL
patients	NULL
.	NULL

The	NULL
physiological	NULL
role	NULL
of	NULL
the	NULL
described	NULL
y	NULL
,	NULL
.	NULL

independent	NULL
IL-4R	NULL
pathway	NULL
in	NULL
normal	NULL
individuals	NULL
as	NULL
well	NULL
as	NULL
in	NULL
patients	NULL
with	NULL
X-SCID	NULL
awaits	NULL
further	NULL
investigation	NULL
.	NULL

Acknowledgments-We	NULL
are	NULL
grateful	NULL
to	NULL
Drs	NULL
.	NULL

R.	NULL
Callard	NULL
,	NULL
C.	NULL
Rooney	NULL
,	NULL
W.	NULL
Leonard	NULL
,	NULL
J.	NULL
DiSanto	NULL
,	NULL
G.	NULL
de	NULL
Saint	NULL
Basile	NULL
,	NULL
and	NULL
A.	NULL
Fischer	NULL
for	NULL
their	NULL
valuable	NULL
suggestions	NULL
.	NULL

We	NULL
thank	NULL
M.	NULL
Sitton	NULL
for	NULL
his	NULL
support	NULL
and	NULL
critical	NULL
comments	NULL
on	NULL
the	NULL
manuscript	NULL
.	NULL

We	NULL
appreciate	NULL
the	NULL
assistance	NULL
of	NULL
M.	NULL
Dao	NULL
.	NULL

REFERENCES	NULL
1.	NULL
WHO	NULL
Scientific	NULL
Group	NULL
on	NULL
Immunodeficiency	NULL
(	NULL
1992	NULL
)	NULL
Immunodefic	NULL
.	NULL

Rev	NULL
.	NULL

8	NULL
,	NULL
195-236	NULL
2	NULL
.	NULL

Noguchi	NULL
,	NULL
M.	NULL
,	NULL
Yi	NULL
,	NULL
H.	NULL
,	NULL
Rosenblatt	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
Filipovich	NULL
,	NULL
A.	NULL
H.	NULL
,	NULL
Adelstein	NULL
,	NULL
S.	NULL
,	NULL
Modi	NULL
,	NULL
W.	NULL
S.	NULL
,	NULL
McBride	NULL
,	NULL
O.	NULL
W.	NULL
,	NULL
and	NULL
Leonard	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Cell	NULL
78	NULL
,	NULL
147-157	NULL
3	NULL
.	NULL

Puck	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Deschenes	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Porter	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Dutra	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Brown	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Willard	NULL
,	NULL
H.	NULL
F.	NULL
,	NULL
and	NULL
Henthorn	NULL
,	NULL
P.	NULL
S.	NULL
(	NULL
1993	NULL
)	NULL
Hum	NULL
.	NULL

Mol	NULL
.	NULL

Genet	NULL
.	NULL

2	NULL
,	NULL
1099-1104	NULL
4	NULL
.	NULL

DiSanto	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Dautry-Varsat	NULL
,	NULL
A.	NULL
,	NULL
Certain	NULL
,	NULL
S.	NULL
,	NULL
Fischer	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
de	NULL
Saint	NULL
Basile	NULL
,	NULL
G.	NULL
(	NULL
1994	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

24	NULL
,	NULL
415-479	NULL
5	NULL
.	NULL

Noguchi	NULL
,	NULL
M.	NULL
,	NULL
Nakamura	NULL
,	NULL
Y.	NULL
,	NULL
Russell	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Ziegler	NULL
,	NULL
S.	NULL
F.	NULL
,	NULL
Tsang	NULL
,	NULL
M.	NULL
,	NULL
Cao	NULL
,	NULL
X.	NULL
,	NULL
and	NULL
Leonard	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Science	NULL
262	NULL
,	NULL
1877-1880	NULL
6	NULL
.	NULL

Russell	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Keegan	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
Harada	NULL
,	NULL
N.	NULL
,	NULL
Nakamura	NULL
,	NULL
Y.	NULL
,	NULL
Noguchi	NULL
,	NULL
M.	NULL
,	NULL
Leland	NULL
,	NULL
P.	NULL
,	NULL
Friedmann	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Miyajima	NULL
,	NULL
A.	NULL
,	NULL
Puri	NULL
,	NULL
R.	NULL
K.	NULL
,	NULL
Paul	NULL
,	NULL
W.	NULL
E.	NULL
,	NULL
and	NULL
Leonard	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

(	NULL
19938	NULL
)	NULL
Science	NULL
262	NULL
,	NULL
1880-1883	NULL
7	NULL
.	NULL

Kondo	NULL
,	NULL
M.	NULL
,	NULL
Takeshita	NULL
,	NULL
T.	NULL
,	NULL
Higuchi	NULL
,	NULL
M.	NULL
,	NULL
Nakamura	NULL
,	NULL
M.	NULL
,	NULL
Sudo	NULL
,	NULL
T.	NULL
,	NULL
Nishikawa	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Sugamura	NULL
,	NULL
K.	NULL
(	NULL
1994	NULL
)	NULL
Science	NULL
268	NULL
,	NULL
1453-1454	NULL
8	NULL
.	NULL

Giri	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
Ahdich	NULL
,	NULL
M.	NULL
,	NULL
Eisenman	NULL
,	NULL
J.	NULL
,	NULL
Shanebeck	NULL
,	NULL
K.	NULL
,	NULL
Grabstein	NULL
,	NULL
K.	NULL
,	NULL
Kumaki	NULL
,	NULL
S.	NULL
,	NULL
Namen	NULL
,	NULL
A.	NULL
,	NULL
Park	NULL
,	NULL
L.	NULL
S.	NULL
,	NULL
Cosman	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Anderson	NULL
,	NULL
D.	NULL
(	NULL
1994	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

13	NULL
,	NULL
2822-2830	NULL
9	NULL
.	NULL

Kimura	NULL
,	NULL
Y.	NULL
,	NULL
Takeshita	NULL
,	NULL
T.	NULL
,	NULL
Kondo	NULL
,	NULL
M.	NULL
,	NULL
Ishii	NULL
,	NULL
N.	NULL
,	NULL
Nakamura	NULL
,	NULL
M.	NULL
,	NULL
Van	NULL
Snick	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Sugamura	NULL
,	NULL
K.	NULL
(	NULL
1995	NULL
)	NULL
Int	NULL
.	NULL

Immunol	NULL
.	NULL

7	NULL
,	NULL
115-120	NULL
10	NULL
.	NULL

Paul	NULL
,	NULL
W.	NULL
E.	NULL
(	NULL
1991	NULL
)	NULL
Blood	NULL
77	NULL
,	NULL
1859-1870	NULL
11	NULL
.	NULL

Kondo	NULL
,	NULL
M.	NULL
,	NULL
Takeshita	NULL
,	NULL
T.	NULL
,	NULL
Ishii	NULL
,	NULL
N.	NULL
,	NULL
Nakamura	NULL
,	NULL
M.	NULL
,	NULL
Watanabe	NULL
,	NULL
S.	NULL
,	NULL
Arai	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Sugamura	NULL
,	NULL
K.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
262	NULL
,	NULL
1874-1877	NULL
12	NULL
.	NULL

Thle	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Nature	NULL
877	NULL
,	NULL
591-594	NULL
13	NULL
.	NULL

Taniguchi	NULL
,	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
Science	NULL
268	NULL
,	NULL
251-255	NULL
14	NULL
.	NULL

Miyazaki	NULL
,	NULL
T.	NULL
,	NULL
Kawahara	NULL
,	NULL
A.	NULL
,	NULL
Fujii	NULL
,	NULL
H.	NULL
,	NULL
Nakagawa	NULL
,	NULL
Y.	NULL
,	NULL
Minami	NULL
,	NULL
Y.	NULL
,	NULL
Liu	NULL
,	NULL
Z-	NULL
J.	NULL
,	NULL
Oishi	NULL
,	NULL
L.	NULL
,	NULL
Silvennoinen	NULL
,	NULL
O.	NULL
,	NULL
Witthubn	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
Thile	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
and	NULL
Taniguchi	NULL
,	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
Science	NULL
266	NULL
,	NULL
1045-1047	NULL
15	NULL
.	NULL

Johnston	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Kawamura	NULL
,	NULL
M.	NULL
,	NULL
Kirken	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Chen	NULL
,	NULL
Y.	NULL
Q.	NULL
,	NULL
Blake	NULL
,	NULL
T.	NULL
B.	NULL
,	NULL
Shibuya	NULL
,	NULL
K.	NULL
,	NULL
Ortaldo	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
McVicar	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
and	NULL
O'Shea	NULL
,	NULL
J.	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Nature	NULL
3870	NULL
,	NULL
151-153	NULL
16	NULL
.	NULL

Russell	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Johnston	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Noguchi	NULL
,	NULL
M.	NULL
,	NULL
Kawamura	NULL
,	NULL
M.	NULL
,	NULL
Bacon	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Friedmann	NULL
,	NULL
M.	NULL
,	NULL
Berg	NULL
,	NULL
M.	NULL
,	NULL
McVicar	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Witthuhn	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
Silvennoinen	NULL
,	NULL
O.	NULL
,	NULL
Goldman	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Schmalsteig	NULL
,	NULL
F.	NULL
C.	NULL
,	NULL
Thle	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
O'Shea	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
and	NULL
Leonard	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Science	NULL
266	NULL
,	NULL
1042-1045	NULL
17	NULL
.	NULL

Witthubn	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
Silvennoinen	NULL
,	NULL
O.	NULL
,	NULL
Miura	NULL
,	NULL
O.	NULL
,	NULL
Lai	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
Cwik	NULL
,	NULL
C.	NULL
,	NULL
Liu	NULL
,	NULL
E.	NULL
T.	NULL
,	NULL
and	NULL
Thle	NULL
,	NULL
J.	NULL
N.	NULL
(	NULL
1994	NULL
)	NULL
Nature	NULL
870	NULL
,	NULL
158-157	NULL
18	NULL
.	NULL

Kotanides	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Reich	NULL
,	NULL
N.	NULL
C.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
262	NULL
,	NULL
1265-1267	NULL
19	NULL
.	NULL

Hou	NULL
,	NULL
J.	NULL
,	NULL
Schindler	NULL
,	NULL
U.	NULL
,	NULL
Henzel	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
Ho	NULL
,	NULL
T.	NULL
C.	NULL
,	NULL
Brasseur	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
McKnight	NULL
S.	NULL
L.	NULL
(	NULL
1994	NULL
)	NULL
Science	NULL
265	NULL
,	NULL
1701-1706	NULL
20	NULL
.	NULL

Schindler	NULL
,	NULL
C.	NULL
,	NULL
Kashleva	NULL
,	NULL
H.	NULL
,	NULL
Pernis	NULL
,	NULL
A.	NULL
,	NULL
Pine	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Rothman	NULL
,	NULL
P.	NULL
(	NULL
1994	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

18	NULL
,	NULL
1350-1356	NULL
21	NULL
.	NULL

Fenghao	NULL
,	NULL
X.	NULL
,	NULL
Saxon	NULL
,	NULL
A.	NULL
,	NULL
Nguyen	NULL
,	NULL
A.	NULL
,	NULL
Ke	NULL
,	NULL
Z.	NULL
,	NULL
Diaz-Sanchez	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Nel	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

96	NULL
,	NULL
907-914	NULL
22	NULL
.	NULL

Kaplan	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
Schindler	NULL
,	NULL
U.	NULL
,	NULL
Smiley	NULL
,	NULL
S.	NULL
T.	NULL
,	NULL
and	NULL
Grusby	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Immunity	NULL
4	NULL
,	NULL
318-319	NULL
23	NULL
.	NULL

Shimoda	NULL
,	NULL
K.	NULL
,	NULL
Vandeursen	NULL
,	NULL
J.	NULL
,	NULL
Sangster	NULL
,	NULL
M.	NULL
Y.	NULL
,	NULL
Srawar	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
Carson	NULL
,	NULL
R.	NULL
T.	NULL
Tripp	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Chu	NULL
,	NULL
C.	NULL
,	NULL
Quelle	NULL
,	NULL
F.	NULL
W.	NULL
,	NULL
Nosaka	NULL
,	NULL
T.	NULL
,	NULL
Vignali	NULL
,	NULL
D.	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
Doherty	NULL
,	NULL
P.	NULL
C.	NULL
,	NULL
Grosveld	NULL
,	NULL
G.	NULL
,	NULL
Paul	NULL
,	NULL
W.	NULL
E.	NULL
,	NULL
and	NULL
Thle	NULL
,	NULL
J.	NULL
N.	NULL
(	NULL
1996	NULL
)	NULL
Nature	NULL
880	NULL
,	NULL
630-633	NULL
24	NULL
.	NULL

Takata	NULL
,	NULL
K.	NULL
,	NULL
Tanaka	NULL
,	NULL
T.	NULL
,	NULL
Shi	NULL
,	NULL
W.	NULL
,	NULL
Matsumoto	NULL
,	NULL
M.	NULL
,	NULL
Minami	NULL
,	NULL
M.	NULL
,	NULL
Kashiwamura	NULL
,	NULL
S.	NULL
,	NULL
Nakanishi	NULL
,	NULL
K.	NULL
,	NULL
Yoshida	NULL
,	NULL
N.	NULL
,	NULL
Kishimoto	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Akira	NULL
,	NULL
S.	NULL
(	NULL
1996	NULL
)	NULL
Nature	NULL
380	NULL
,	NULL
627-630	NULL
25	NULL
.	NULL

Izuhara	NULL
,	NULL
K.	NULL
,	NULL
Heike	NULL
,	NULL
T.	NULL
,	NULL
Otsuka	NULL
,	NULL
T.	NULL
,	NULL
Yamaoka	NULL
,	NULL
K.	NULL
,	NULL
Mayumi	NULL
,	NULL
M.	NULL
,	NULL
Imamura	NULL
,	NULL
T.	NULL
,	NULL
Niho	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Harada	NULL
,	NULL
N.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
,	NULL
619-622	NULL
26	NULL
.	NULL

Russell	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Tayebi	NULL
,	NULL
N.	NULL
,	NULL
Nakajima	NULL
,	NULL
H.	NULL
,	NULL
Riedy	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Roberts	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Aman	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Migone	NULL
,	NULL
T.	NULL
S.	NULL
,	NULL
Noguchi	NULL
,	NULL
M.	NULL
,	NULL
Markert	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
Buckley	NULL
,	NULL
R.	NULL
H.	NULL
,	NULL
O'Shea	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
and	NULL
Leonard	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Science	NULL
270	NULL
,	NULL
797-800	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

82	NULL
.	NULL

33	NULL
.	NULL

84	NULL
.	NULL

85	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

IL-4	NULL
Signaling	NULL
in	NULL
X-SCID	NULL
B	NULL
Cells	NULL
Matthews	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Clark	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Herbert	NULL
,	NULL
J.	NULL
,	NULL
Morgan	NULL
,	NULL
G.	NULL
,	NULL
Armitage	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Kinnon	NULL
,	NULL
C.	NULL
,	NULL
Minty	NULL
,	NULL
A.	NULL
,	NULL
Grabstein	NULL
,	NULL
K.	NULL
H.	NULL
,	NULL
Caput	NULL
,	NULL
D.	NULL
,	NULL
Ferrara	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Callard	NULL
,	NULL
R.	NULL
E.	NULL
(	NULL
1995	NULL
)	NULL
Blood	NULL
85	NULL
,	NULL
38-42	NULL
Puck	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Pepper	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
Bedard	NULL
,	NULL
P.-M.	NULL
,	NULL
and	NULL
Laframboise	NULL
,	NULL
R.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

95	NULL
,	NULL
895-599	NULL
Pepper	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
Buckley	NULL
,	NULL
R.	NULL
H.	NULL
,	NULL
Small	NULL
,	NULL
T.	NULL
N.	NULL
,	NULL
and	NULL
Puck	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
Am	NULL
.	NULL

J.	NULL
Hum	NULL
.	NULL

Genet	NULL
.	NULL

57	NULL
,	NULL
564-571	NULL
Candotti	NULL
,	NULL
F.	NULL
,	NULL
Johnston	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Puck	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Sugamura	NULL
,	NULL
K.	NULL
,	NULL
O'Shea	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
and	NULL
Blaese	NULL
,	NULL
R.	NULL
M.	NULL
(	NULL
1996	NULL
)	NULL
Blood	NULL
87	NULL
,	NULL
3097-3102	NULL
Taylor	NULL
,	NULL
N.	NULL
,	NULL
Uribe	NULL
,	NULL
L.	NULL
,	NULL
Smith	NULL
,	NULL
S.	NULL
,	NULL
Jahn	NULL
,	NULL
T.	NULL
,	NULL
Kohn	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
and	NULL
Weinberg	NULL
,	NULL
K.	NULL
(	NULL
1996	NULL
)	NULL
Blood	NULL
87	NULL
,	NULL
3108-8107	NULL
Finbloom	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
Peticoin	NULL
,	NULL
E.	NULL
F.	NULL
,	NULL
Hackett	NULL
,	NULL
R.	NULL
H.	NULL
,	NULL
David	NULL
,	NULL
M.	NULL
,	NULL
Feldman	NULL
,	NULL
G.	NULL
M.	NULL
,	NULL
Igarashi	NULL
,	NULL
K.	NULL
,	NULL
Fibach	NULL
,	NULL
E.	NULL
,	NULL
Weber	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Thorner	NULL
,	NULL
M.	NULL
O.	NULL
,	NULL
Silva	NULL
,	NULL
C.	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
2118-2118	NULL
Yin	NULL
,	NULL
T.	NULL
,	NULL
Tsang	NULL
,	NULL
M.	NULL
L.-S.	NULL
,	NULL
and	NULL
Chang	NULL
,	NULL
Y.-C.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
26614-26617	NULL
Pearse	NULL
,	NULL
R.	NULL
N.	NULL
,	NULL
Feinman	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Ravetch	NULL
,	NULL
J.	NULL
V.	NULL
(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

88	NULL
,	NULL
11805-11309	NULL
Wang	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
Myers	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
Jr.	NULL
,	NULL
Sun	NULL
,	NULL
X.	NULL
J.	NULL
,	NULL
Aaronson	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
White	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Pierce	NULL
J.	NULL
H.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
261	NULL
,	NULL
1591-1594	NULL
Keegan	NULL
,	NULL
A.	NULL
,	NULL
Nelms	NULL
,	NULL
K.	NULL
,	NULL
White	NULL
,	NULL
M.	NULL
,	NULL
Wang	NULL
,	NULL
L.-M.	NULL
,	NULL
Pierce	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
and	NULL
Paul	NULL
,	NULL
W.	NULL
E.	NULL
(	NULL
1994	NULL
)	NULL
Cell	NULL
76	NULL
,	NULL
811-820	NULL
Quelle	NULL
,	NULL
F.	NULL
W.	NULL
,	NULL
Shimoda	NULL
,	NULL
K.	NULL
,	NULL
Thierfelder	NULL
,	NULL
W.	NULL
,	NULL
Fischer	NULL
,	NULL
C.	NULL
,	NULL
Kim	NULL
,	NULL
A.	NULL
,	NULL
Ruben	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Cleveland	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Pierce	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
Keegan	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
Nelms	NULL
,	NULL
K.	NULL
,	NULL
Paul	NULL
,	NULL
W.	NULL
E.	NULL
,	NULL
and	NULL
Thle	NULL
,	NULL
J.	NULL
N.	NULL
(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
8336-3343	NULL
Minty	NULL
,	NULL
A.	NULL
,	NULL
Chalon	NULL
,	NULL
P.	NULL
,	NULL
Derocq	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Dumont	NULL
,	NULL
X.	NULL
,	NULL
Guillemot	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Kaghad	NULL
,	NULL
M.	NULL
,	NULL
Labit	NULL
,	NULL
C.	NULL
,	NULL
Leplatois	NULL
,	NULL
P.	NULL
,	NULL
Liauzun	NULL
,	NULL
P.	NULL
,	NULL
Miloux	NULL
,	NULL
B.	NULL
,	NULL
Minty	NULL
,	NULL
C.	NULL
,	NULL
Casellas	NULL
,	NULL
P.	NULL
,	NULL
Loison	NULL
,	NULL
G.	NULL
,	NULL
Lupker	NULL
,	NULL
J.	NULL
,	NULL
Shire	NULL
,	NULL
D.	NULL
,	NULL
Ferrara	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Caput	NULL
,	NULL
D.	NULL
(	NULL
1998	NULL
)	NULL
Nature	NULL
362	NULL
,	NULL
248-250	NULL
Zurawski	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
de	NULL
Vries	NULL
,	NULL
J.	NULL
E.	NULL
(	NULL
1994	NULL
)	NULL
Immunol	NULL
.	NULL

Today	NULL
15	NULL
,	NULL
19-26	NULL
Callard	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
Matthews	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
and	NULL
Hibbert	NULL
,	NULL
L.	NULL
(	NULL
1996	NULL
)	NULL
Immunol	NULL
.	NULL

Today	NULL
17	NULL
,	NULL
108-110	NULL
Conrad	NULL
,	NULL
D.	NULL
H.	NULL
,	NULL
Waldschmidt	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
Lee	NULL
,	NULL
W.	NULL
T.	NULL
,	NULL
Rao	NULL
,	NULL
M.	NULL
,	NULL
Keegan	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
Noelle	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Lynch	NULL
,	NULL
R.	NULL
G.	NULL
,	NULL
and	NULL
Kehry	NULL
,	NULL
M.	NULL
R.	NULL
(	NULL
1987	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

189	NULL
,	NULL
2290-2296	NULL
Ryan	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
McReynolds	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
Keegan	NULL
,	NULL
A.	NULL
,	NULL
Wang	NULL
,	NULL
L.-H.	NULL
,	NULL
Garfein	NULL
,	NULL
E.	NULL
,	NULL
Rothman	NULL
,	NULL
P.	NULL
,	NULL
Nelms	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Paul	NULL
,	NULL
W.	NULL
E.	NULL
(	NULL
1996	NULL
)	NULL
Immunity	NULL
4	NULL
,	NULL
128-132	NULL
Johnston	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Bacon	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Reidy	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
and	NULL
O	NULL
Shea	NULL
,	NULL
J.	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
J.	NULL
Leukocyte	NULL
Biol	NULL
.	NULL

60	NULL
,	NULL
411-452	NULL
Wang	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
Keegan	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
Frankel	NULL
,	NULL
M.	NULL
,	NULL
Paul	NULL
,	NULL
W.	NULL
E.	NULL
,	NULL
and	NULL
Pierce	NULL
,	NULL
J.	NULL
H.	NULL
(	NULL
1995	NULL
)	NULL
45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50.	NULL
.	NULL

Murata	NULL
,	NULL
T.	NULL
,	NULL
Noguchi	NULL
,	NULL
P.	NULL
D.	NULL
,	NULL
and	NULL
Puri	NULL
,	NULL
R.	NULL
K.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

156	NULL
,	NULL
2972-2978	NULL
52	NULL
.	NULL

EA	NULL
54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

7319	NULL
Stem	NULL
Cells	NULL
18	NULL
,	NULL
360-368	NULL
Johnston	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Wang	NULL
,	NULL
L.-M.	NULL
,	NULL
Hanson	NULL
,	NULL
E.	NULL
P.	NULL
,	NULL
Sun	NULL
,	NULL
X.-J	NULL
.	NULL

,	NULL
White	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
Oakes	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Pierce	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
and	NULL
O'Shea	NULL
,	NULL
J.	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
28527-28530	NULL
Murata	NULL
,	NULL
T.	NULL
,	NULL
Noguchi	NULL
,	NULL
P.	NULL
D.	NULL
,	NULL
and	NULL
Puri	NULL
,	NULL
R.	NULL
K.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
30829-30836	NULL
Palmer-Crocker	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Hughes	NULL
,	NULL
C.	NULL
C.	NULL
W.	NULL
,	NULL
and	NULL
Pober	NULL
,	NULL
J.	NULL
S.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

98	NULL
,	NULL
604-609	NULL
Izuhara	NULL
,	NULL
K.	NULL
,	NULL
Feldman	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Greer	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Harada	NULL
,	NULL
N.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
18623-18629	NULL
Oakes	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Candotti	NULL
,	NULL
F.	NULL
,	NULL
Johnston	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Chen	NULL
,	NULL
Y.-Q	NULL
.	NULL

,	NULL
Ryan	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
Taylor	NULL
,	NULL
N.	NULL
,	NULL
Lio	NULL
,	NULL
X.	NULL
,	NULL
Henninghausen	NULL
,	NULL
L.	NULL
,	NULL
Notarangelo	NULL
,	NULL
L.	NULL
D.	NULL
,	NULL
Paul	NULL
,	NULL
W.	NULL
E.	NULL
,	NULL
Blaese	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
and	NULL
O'Shea	NULL
,	NULL
J.	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Immunity	NULL
5	NULL
,	NULL
605-616	NULL
He	NULL
,	NULL
Y.-W.	NULL
,	NULL
and	NULL
Malek	NULL
,	NULL
T.	NULL
R.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

155	NULL
,	NULL
9-12	NULL
Obiri	NULL
,	NULL
N.	NULL
I.	NULL
,	NULL
Debinski	NULL
,	NULL
W.	NULL
,	NULL
Leonard	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
and	NULL
Puri	NULL
,	NULL
R.	NULL
K.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
8797-8804	NULL
Lefort	NULL
,	NULL
S.	NULL
,	NULL
Vita	NULL
,	NULL
N.	NULL
,	NULL
Reeb	NULL
,	NULL
R.	NULL
,	NULL
Caput	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Ferrara	NULL
,	NULL
P.	NULL
(	NULL
1995	NULL
)	NULL
FEBS	NULL
Lett	NULL
.	NULL

366	NULL
,	NULL
122-126	NULL
Zurawski	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Chomarat	NULL
,	NULL
P.	NULL
,	NULL
Djossou	NULL
,	NULL
O.	NULL
,	NULL
Bidaud	NULL
,	NULL
C.	NULL
,	NULL
McKenzie	NULL
,	NULL
A.	NULL
N.	NULL
J.	NULL
,	NULL
Miossec	NULL
,	NULL
P.	NULL
,	NULL
Banchereau	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Zurawski	NULL
,	NULL
G.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
13869-13878	NULL
Lin	NULL
,	NULL
J.-X	NULL
.	NULL

,	NULL
Migone	NULL
,	NULL
T.-S.	NULL
,	NULL
Tsang	NULL
,	NULL
M.	NULL
,	NULL
Friedmann	NULL
,	NULL
M.	NULL
,	NULL
Weatherbee	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Zhou	NULL
,	NULL
L.	NULL
,	NULL
Yamauchi	NULL
,	NULL
A.	NULL
,	NULL
Bloom	NULL
,	NULL
E.	NULL
T.	NULL
,	NULL
Mictz	NULL
,	NULL
J.	NULL
,	NULL
John	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Leonard	NULL
,	NULL
W.	NULL
(	NULL
1995	NULL
)	NULL
Immunity	NULL
2	NULL
,	NULL
881-839	NULL
Vita	NULL
,	NULL
N.	NULL
,	NULL
Lefort	NULL
,	NULL
S.	NULL
,	NULL
Laurent	NULL
,	NULL
P.	NULL
,	NULL
Caput	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Ferrara	NULL
,	NULL
P.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
BioL	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
8512-8517	NULL
Schnyder	NULL
,	NULL
B.	NULL
,	NULL
Lugli	NULL
,	NULL
S.	NULL
,	NULL
Feng	NULL
,	NULL
N.	NULL
,	NULL
Etter	NULL
,	NULL
H.	NULL
,	NULL
Lutz	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Ryffel	NULL
,	NULL
B.	NULL
,	NULL
Sugamura	NULL
,	NULL
K.	NULL
,	NULL
Wunderli-Allenspack	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Moser	NULL
,	NULL
R.	NULL
(	NULL
1996	NULL
)	NULL
Blood	NULL
87	NULL
,	NULL
4286-4295	NULL
Welham	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Learmonth	NULL
,	NULL
L.	NULL
,	NULL
Bone	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Schrader	NULL
,	NULL
J.	NULL
W.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
12286-12296	NULL
Smerz-Bertling	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Duschl	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
966-970	NULL
Keegan	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
Johnston	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Tortolani	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
McReynolds	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
Kinzer	NULL
,	NULL
C.	NULL
,	NULL
O'Shea	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
and	NULL
Paul	NULL
,	NULL
W.	NULL
E.	NULL
(	NULL
1995	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

92	NULL
,	NULL
7681-7685	NULL
Hilton	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Zhang	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
Metcalf	NULL
,	NULL
D.	NULL
,	NULL
Alexander	NULL
,	NULL
W.	NULL
S.	NULL
,	NULL
Nicola	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
and	NULL
Willson	NULL
,	NULL
T.	NULL
A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

98	NULL
,	NULL
497-501	NULL
Caput	NULL
,	NULL
D.	NULL
,	NULL
Laurent	NULL
,	NULL
P.	NULL
,	NULL
Kaghad	NULL
,	NULL
M.	NULL
,	NULL
Lelias	NULL
,	NULL
J.-M.	NULL
,	NULL
Lefort	NULL
,	NULL
S.	NULL
,	NULL
Vita	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Ferrara	NULL
,	NULL
P.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
,	NULL
16921-16926	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
Interleukin-4	NULL
Signaling	NULL
in	NULL
B	NULL
Lymphocytes	NULL
from	NULL
Patients	NULL
with	NULL
X-linked	NULL
Severe	NULL
Combined	NULL
Immunodeficiency	NULL
Naomi	NULL
Taylor	NULL
,	NULL
Fabio	NULL
Candotti	NULL
,	NULL
Susan	NULL
Smith	NULL
,	NULL
Scott	NULL
A.	NULL
Oakes	NULL
,	NULL
Thomas	NULL
Jahn	NULL
,	NULL
Judith	NULL
Isakov	NULL
,	NULL
Jennifer	NULL
M.	NULL
Puck	NULL
,	NULL
John	NULL
J.	NULL
O'Shea	NULL
,	NULL
Kenneth	NULL
Weinberg	NULL
and	NULL
James	NULL
A.	NULL
Johnston	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1997	NULL
,	NULL
272:7314-7319.	NULL
doi	NULL
:	NULL
10.1074/jb0.272.11.7314	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/272/1	NULL
1/7314	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
62	NULL
references	NULL
,	NULL
35	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
1/7314	NULL
.	NULL

610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL

